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I 
INTRODUCTION TO BOVINE PAPILLOMAVIRUSES 
1 General characteristics  
1.1 History 
In many cultures, warts have been associated with magic and a multitude of folk cures, due to 
their sudden appearance and disappearance (Bunney et al., 1992). Already in the writings of 
the Byzantine physician Aetius of Amida (sixth century AD), it was possible to find the 
description of papillomatous lesions: ‘‘The term thymus arises from the similarity to the tips 
of the plant of the same name, which grows in the mountains. It appears in the anus and the 
pudenda and between the legs’’. Aulus Cornelius Celsus, who lived during the reign of 
Tiberius Caesar, in discussing wart-like lesions in his book “De Medecina” described three 
morphologically distinct types of cutaneous warts, but the most common term 'verruca' was 
firstly used by the German Daniel Sennert (1572–1637) in his book entitled “Hypomnemata 
physicae” (1636) describeing that “they appear on the surface of the skin like the eminences 
of little hills”. 
In the past, theories about the causation of warts abounded: in 1849, a medical section of the 
Lancet stated that “Dr Durr frequently observed warts on index and middle finger of females 
addicted to solitary habit”, alluding to masturbation. Folklore in fact provides a rich source of 
theories of the cause of warts, like repeated wetting of the hands, washing the hands in water 
in which eggs have been boiled, the killing of a toad, the foam of the sea-shore and contact 
with animals, particularly cows and chickens.  
Obviously, popular belief on treatment of warts abounded, including animal, plant or mineral 
remedies consisting of local applications of fish heads, pig's blood, pig's fat, lizard's blood, 
menstrual blood, dog's dung, dove's dung, tobacco juice and fasting spittle (Bett, 1951).  
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It was only in 1823 that Sir Astley Cooper introduced the concept of a transmissible agent as 
responsible for wart causation, while in 1891 Joseph Payne recorded their contagious nature, 
subsequently confirmed with inoculation experiments (Variot, 1894; Jadassohn, 1896). The 
probable viral origin of warts was suggested by Ciuffo who produced warts on his hands by 
inoculating himself with a wart extract filtered in order to exclude bacteria and fungi, in 1907; 
subsequently in 1919 Wile and Kingery transmitted warts in human beings, and Kingery 
(1921) a couple of years later was also able to produce them in the second generation with 
filtrates. 
HPV virus particles in warts were firstly demonstrated on EM in 1949 by Strauss and 
colleagues but only in 1962 Melnick classified the wart virus in the Papova virus group. 
So far, observations of warts had been reported in different animal species (Penbertby 1898; 
Cook and Olson 1951; Moulton, 1954; Shope and Hurst 1933; Lucke et al 1950), and in the 
70s it was determined that the causative agents were several diverse viruses.  
Contagiousness of warts in animals was recognized at the beginning of the XX century in 
cattle and water buffalo (Cadeac, 1901; Royer, 1902; Schindelka, 1903; Da Costa, 1906) 
where it was noticed that the subject could develop a fibropapilloma after inoculation of 
scarified skin with the bovine papilloma agent. In such lesions, the demonstration of the 
presence of a filtrable agent was performed only in 1929 (Creech), while in 1933 the so called 
CRPV (Cottontail Rabbit Papillomavirus) was recognized as the first DNA oncovirus and was 
also the first animal PV to be identified by Shope. In cattle it was later observed that the virus 
was also responsible for the development of fibropapilloma of the genital mucosa (Mcentee, 
1952) and a polyp-like tumor in the urinary bladder (Olson et al., 1959), as well as a sarcoma-
like condition in the skin of the horse (Olson et al., 1951). While in 1959 it was also shown 
that regressing tumors of the bladder could be induced by wart extracts, demonstrating that 
BPVs cause bladder neoplasia (Olson et al., 1959).  
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In humans, Human Papilloma Virus (HPV) has been identified as a major public health 
problem to such an extent that the 2008 Nobel Prize in Physiology or Medicine went to 
Harald zur Hausen, who discovered the role that HPV plays in the pathogenesis of cervical 
cancer, prompting much research on the nature and mechanism of papillomavirus-induced 
oncogenesis, which in turn has advanced understanding of papillomavirus infections in 
animals. In fact, the virus infectious cycle and the neoplastic progression from papilloma to 
carcinoma are broadly similar in humans and animals (Table 1), and animal PVs and their 
hosts represent excellent model systems for HPVs, infection and neoplastic progression 
(Borzacchiello et al., 2009; Campo, 2002) as well as vaccination study in the natural host. 
  
  
 
Figure 1- This cow was inoculated with BPV1 virus by Carl Olson at the University 
of Wisconsin. The warts were harvested by Carl Baker and Paul Lambert and the 
material obtained (virus, tissue sections and RNA) was used for many of the key 
studies of BPV1 biology.    
       
 
 
Observations on BPVs 
made 50 years  ago 
Subsequently determined relevance in 
HPVs 
BPVs may cause cancer HPVs now estimated to cause 5% of human 
cancer 
BPV infection shows difference 
manifestation depending on host 
factors 
The immune response of the host strongly 
influences the manifestation of HPV 
infection 
 
BPVs can infet cells other than 
mucocutaneous epithelial cells 
A diverse range of cancer are currently 
being investigated for a possivle 
manifestation of HPV infection 
Determining the significance of BPV in a  
tumor can be difficult 
While HPVs have been detected in many 
different human cancers, their 
ubiquitous  nature makes it hard to 
assign significance 
BPVs can infect multiple species Although rare, cross-species infections by 
HPVs has been reported 
 
Table 1- Observations on Bovine Papillomaviruses (BPVs) made prior to or in the paper by 
Cheville and Olson, published in veterinary pathology in 1964, and the subsequently 
determined relevance to Human Papillomavirus (HPV) biology. Modified from Munday et al. 2014. 
 
 
4 
1.2 Taxonomy  
The actual classification of the papillomaviruses into the family Papillomaviridae was 
proposed in the 7
th
 ICTV report (2000) and entered into force in 2003 (de Villiers, 2013). In 
fact, formerly, papillomaviruses and polyomaviruses were grouped into the family 
Papovaviridae based on their structural similarities, but later it was demonstrated that they 
have different genome sizes, completely different organizations, and no major nucleotide or 
amino acid sequence similarities except for the presence of some local homologies. PVs’ 
taxonomy in the past has been performed in many ways: comparing panels of restriction 
digests, via cross-wise southern blot hybridizations, under non stringent conditions, and liquid 
hybridizations, furthermore, PVs do not elicit robust antibody responses in the course of 
natural infections, which impeded a classification based on “serotype” designations.  
Determination of PV genotypes is nowadays based on their degree of homology, where the 
frequency distribution of pairwise identity percentages of L1 genes demonstrates three main 
taxonomic levels, namely genera, species and types (de Villiers et al., 2004).  
Different genera, designated by Greek letters, share less than 60% nucleotide sequence 
identity in the L1 ORF and less than 23% to 43% when their full genomic sequences are 
compared. The classification of PVs into genera unites several phylogenetically related 
species, previously called ‘‘supergroups’’ or ‘‘major branches’’ (Myers et al., 1994; Chan et 
al., 1995), that differ with respect to their biological properties. Different species within the 
same genus exhibit 60-70% similarity in their L1 ORFs. The term ‘‘species’’ is biologically 
useful, as these are natural taxa based on a close phylogenetic relationship of certain types 
and because such species typically lump PV types which have common biological and 
pathological properties, which is a requirement of ICTV guidelines. A new viral type must 
have a completely cloned genome and the DNA sequence of the L1 region must differ by 
>10% of the closest known type. Nomenclature is based on the scientific name of the host 
species followed by a progressive number, based on the publication date of the virus and/or 
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the submission of the sequence to a public database and deposit of the cloned viral genome. 
Only the human and bovine papillomaviruses are designated with the historical abbreviations 
“HPV” (with H standing for human or Homo, but avoiding the species designation “sapiens”) 
and “BPV” (with B standing for bovine or Bos, but avoiding the species designation “taurus”) 
respectively (Bernard et al., 2010). Reference type species are identified either because they 
are the most comprehensively investigated type, or because they represent best the species, or 
because there is only one type in that taxon. Papillomavirus genomes with a nucleotide 
sequence identity between 2% and 10% from the L1 ORF in the reference genome have been 
named subtypes, while less than 2% define a variant. Recently the ICTV Papillomavirus 
Study Group proposed a classification and nomenclature criteria for papillomavirus variants 
(Chen et al., 2011) considering the use of full genome sequences. This is derived from the fact 
that isolates of the same type are closely related and the full extent of the sequence 
heterogeneity is best summed across the whole genome and recently evolved variant genomes 
have changes that are not always evenly distributed throughout the genome (Burk et al. 2011).  
Currently, 49 genera, from Treisdeltapapillomavirus to Dyoomegapapillomavirus comprise 
over 318 fully characterized PV types (http://pave.niaid.nih.gov, last access 26 dec 2015). 
Around 180 of them are human isolates, reflecting the fact that human PVs have been 
extensively studied compared with animal PVs (Figure 2). 
The four different genera Delta Epsilon Xi and Dyoxi include the fifteen BPVs (BPV 1-15) 
that have been characterized so far in cattle, even though it has been estimated that type 
number may exceed 20 (Lunardi et al., 2013b).  
The Delta papillomaviruses comprise the ruminant papillomaviruses, in particular BPV types 
1, 2, 13 and 14, whose peculiarity is to cause benign fibropapillomas starting from the 
transformation of subepithelial fibroblasts followed by epithelial acanthosis and then 
papillomatosis. The ability of BPV1 and BPV2 to non-productively transform non-epithelial 
cells is not species-specific, although the increased host range is limited to fibroblasts as 
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further shown by the induction of experimental fibroblastic tumors in hamsters, and focal 
transformation of cultured rodent cells (Cheville, 1966). In vivo, BPV1, 2 and 13 are the only 
papillomaviruses able to cause natural infections outside the primary host causing the 
development of sarcoids in horses (Nasir and Campo, 2008; MacLachlan and Dubovi, 2011; 
Lunardi et al., 2013a, b).  
 
 
Figure 2; the best-known  maximum likelihood phylogenetic tree for PVs. This tree was constructed using the 
concatenated E1–E2–L1 genes, aligned at the amino acid level. Color codes highlight the four PV supertaxa:. 
PVs that cannot be assigned yet with confidence to a supertaxon are labeled in black. Silhouettes represent the 
hosts infected by the corresponding viruses. Adapted from Bravo et al., 2010 
 
Following its first identification, BPV14 was formerly classified as feline sarcoid-associated 
papillomavirus (FeSarPV), but phylogenetic analyses revealed that its sequence was most 
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similar to the Deltapapillomavirus species BPVs 1, 2, and 13, while it was distantly related to 
any carnivoran PV (Munday et al., 2010). Since FeSarPV sequence has never been detected in 
any non-sarcoid sample from cats but has been amplified from the skin of cattle, it was 
hypothesized that feline sarcoids develop due to cross-species infection of cats by a bovine 
Delta-PV as cattle are commonly reared in all countries where feline sarcoids have been 
previously reported (Schulman et al., 2001). 
Epsilonpapillomaviruses comprise BPV5 and 8 whose genomes seem to share similarities 
with both Xi-PVs and Delta-PVs (Bloch and Breen, 1997) and at the same time they appear to 
have a dual pathology causing both fibropapillomas and epithelial papillomas (Bloch et al., 
1994). Xipapillomaviruses include BPV3, 4, 6, 9, 10, 11, 12 and 15 that induce epithelial 
papillomas (de Villiers et al., 2004; Hatama et al., 2008, 2011; Zhu et al., 2012) with 
transformation only of the epithelial component. 
The last genus comprises only BPV7, that has been isolated for the first time in Japan (Ogawa 
et al., 2007), and has been classified as Dyoxipapillomavirus (Rector and Van Ranst, 2013).  
Anyhow, this classification should be considered a guideline and cannot be intended 
definitive since Batista and colleagues (2013) reported a more frequent occurrence of co-
infections and a possible association of pure epitheliotropic types with cutaneous 
fibropapillomas. 
 
1.3 Virus structure  
Like other papillomaviruses, BPV virions are non enveloped, spherical 55 nm in diameter 
with a T=7d icosahedral capsid composed of 360 L1 molecules that can self-assemble into 72 
pentamers (capsomers). The neighboring capsomeres form the capsid that contains a single 
molecule of circular covalently closed, supercoiled dsDNA associated with histones with a 
size up to ~9 Kbp (Figure 3). Both full (Figure 4) and empty virus particles are seen by 
electron microscopy.  
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Figure 3: Papillomaviral structure. Source: ViralZone:  
www.expasy.org/viralzone.  
SIB Swiss Institute of Bioinformatics 
Figure 4: Virus Like Particles 
 
Papillomaviruses are resistant to diverse environmental insults: infectivity survives lipid 
solvents and detergents, low pH, and high temperatures (50°C, 1 hr). Neither lipids nor 
carbohydrates are present, while the virus genomes encode 8-10 proteins with sizes ranging 
from 7-73 kDa (Figure 5). The encoding ORFs (Open Reading Frame) located on a single 
DNA strand can be divided into early (E) and late (L) depending on the time of viral DNA 
replication occurrence. Papillomaviruses show a remarkable conservation in the overall 
genomic organization (Figure 4): the elements shared fom the different genera of the family 
Papillomaviridae are the LCR (Long Control Region) and the E1, E2, L1, L2 ORFs (Vallvè et 
al., 2005; Rector and Van Ranst, 2013).  
 
Figure 5- Molecular organization of BPV1 (A), considered the typical prototype architecture of the 
papillomavirues, and BPV4 (B) genomes. In BPV4, the E6 is replaced by an open reading frame originally 
termed E8 which later was renamed E5 because of its structural and functional similarities to BPV-1 E5 (Jackson 
et al., 1991; Faccini et al., 1996).  
 
 
A 
B 
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Although gene number is limited by the small size of the papillomavirus genome, gene 
expression involves the use of multiple promoters and complex patterns of splicing, 
increasing the number of encoded proteins. 
L1 and L2 make up the capsid and are expressed only in the fully differentiated keratinocytes 
at the surface of the papilloma (Borzacchiello and Roperto, 2008), the remaining are non-
structural proteins (E1-E8). The transformation process is modulated by the three oncogenes, 
E5, E6 and E7, while E1 and E2 modulate transcription and regulation processes (Munger and 
Howley, 2002). The untranslated LCR region contains the origin of replication and the 
binding sites of multiple transcription factors (Zheng and Baker, 2006) and appears to mutate 
at a faster rate than other parts of the PV genome (Rector et al., 2007). 
 
1.4 Evolution 
The fact that PV's phylogeny resembles to some extent the phylogeny of their hosts (Rector, 
et al. 2007; Bernard, 2005) suggest that the main driving factor of PV diversification over 
millions of years (Halpern 2000; Bernard et al., 2006) is the ‘‘host-linked evolution’’ (Chan et 
al. 1992, 1995). 
An ancestral, probably cutaneotropic PV, might have diverged into a small number of 
different PVs linked to the differentiation of mammalian skin (Garcia-Vallve, 2005). 
However, if co-divergence alone was the driving force for the observed PV diversity, then (i) 
all PVs infecting the same host should be monophyletic and (ii) the topologies of the 
phylogenetic trees of hosts and of PVs should be entirely congruent (Bravo et al., 2010). As a 
matter of fact, barely half of the known host–parasite associations appear to derive from co-
phylogenetic events (Gottschling et al., 2011).  
Evolutionary incongruence might arise from singular events in the past such as the 
establishment of new ecological niches, and/or asymmetric genome convergences driven by 
intense selection (Narechania et al. 2005; Varsani et al. 2006), but also within-host virus 
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duplication, viral sorting, or viral adaptation after a host switch, may contribute considerably 
to PV diversification (Shah et al., 2010; Gottschling et al, 2011). 
In particular, evolution upon host switch could ultimately lead to the colonization of a new 
host (Antia et al., 2003). This seems to have been the case with BPV1 and BPV2 in horses, 
where infection can be a result of human domestication of cattle and horses or a phenotypic 
acquisition driven by vector-mediated interspecies transmission (Finlay et al., 2009; 
Gottschling et al., 2011). Thus, concominant ecological changes in the different hosts may 
have increased their susceptibility to BPV cross-infection and/or augmented the frequency of 
physical contact between them to grant BPV improved access to a potential new host 
(Gottschling et al., 2011). Anyhow, the genetic changes in the viral sequences suggest an 
adaptation process to the environment provided by the new host (Nasir and Campo, 2008). 
More examples for heterologous PV infections include the presence of feline sarcoma PV on 
bovine skin (Munday and Knight, 2010), the presence of HPV9 in lesions of a cat (Munday et 
al. 2007), the possible transient infections of zookeepers with animal PVs (Antonsson and 
Hansson, 2002) and interspecies infection between macaques (Chen et al., 2009). 
Nevertheless, the rare occurrence of recombination events is also documented. Besides 
experimental infection in the rabbit model (Hu et al., 2009), in nature it has been reported for 
cetacean papillomaviruses, with recombination breakpoints closely corresponding to the early 
and late genomic regions (Gottschling et al., 2011; Rector et al., 2008; Robles-Sikisaka et al., 
2012), but also the clinically important AlphaPVs (i.e. HPV16, 18) have undergone 
recombination event(s) between the early and the late regions of the genome (Bravo and 
Alonso, 2004; Narechania et al., 2005; Carvajal-Rodriguez 2008). Surprisingly, 
recombination has also been reported between the two families Polyomaviridae and 
Papillomaviridae in the chimeric viruses retrieved from western barred bandicoot (Perameles 
bougainville) (Woolford et al. 2007). 
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2 Interaction of Bovine Papillomaviruses with the cell  
2.1 Replication cycle 
The knowledge regarding papillomavirus replication is originally based on the ability of 
BPV1 to infect and transform the mouse fibroblasts cell line (C127) allowing the virus to 
establish and maintain genomes as extrachromosomal DNA with a constant copy number 
(Lancaster, 1981; Law et al., 1981). Infection does not require the virus capsid, as skin 
abrasion and exposure to the naked viral genome are able to recapitulate the complete natural 
history of the infection in different animal models (Cladel et al., 2008). Papillomaviruses 
infect the mitotically active basal cells, whose replication maintains the infection; subsequent 
cell differentiation triggers the production of the PV early proteins, preventing the suprabasal 
cell from leaving the cell cycle (which would result in nuclear degeneration) and instead 
causing the cell to re-enter the S-phase and produce numerous viral copies. Indeed genome is 
delivered into the nucleus and is episomally maintained at a low copy number. The productive 
infectious cycle needs differentiation and keratinization of the infected cells: early and late 
genes are expressed in a temporal and highly regulated manner leading to the formation of 
lesions that are usually benign and tend to regress, and therefore considered hyperplastic 
rather than neoplastic (Munday, 2014).  
In particular, in the basal and lower levels of the epithelium, the early genes encoding for pro-
mitotic proteins and viral replication factors are expressed, while terminal cell differentiation 
is required for activation of late gene expression and production of viral particles at the very 
top of the epithelium. Virions are shed into the environment from the uppermost layers of the 
epithelium where keratinocytes undergo terminal differentiation steps that ultimately lead to 
desquamation. The life cycle is therefore intra-epithelial, produces no cell lysis, or cell death, 
and replication is not associated with inflammation (Stanley, 2012).  
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PVs are taken up by the cell through endocytosis following primary attachment to the host 
cell, subsequently the uncoating program starts at the plasma membrane by binding to 
heparan sulfate proteoglycan (HSPG) receptors and initiating the first structural changes 
within the capsid.  
The mechanisms of papillomavirus endocytosis have not been fully resolved for all the 
different PV types; it mostly seems like L1 and L1/L2 particles initially traffic similarly, 
passing through early endosomes to late endosomes (Day et al., 2003; Kämper et al., 2006). In 
the latter, the acidification seems also to facilitate the dissociation of the L1 protein from the 
L2/DNA complex in the endosomal compartment (Bienkowska-Haba et al., 2012). 
Trafficking occurs on average 2–3 h post internalization indicating prolonged residence in the 
endosomal system (Schelhaas et al., 2012). After this step, L2 and the genome are transferred 
to the trans-Golgi network prior to nuclear delivery (Day et al., 2013).  
After entry into the nucleoplasm, expression of E1 and E2 results in the production of 10 to 
200 episomal PV copies (Maglennon et al., 2011) and maintaining the keratinocyte in a 
proliferative state. Gene expression is regulated at the level of transcription (Bernard, 2002;) 
and RNA processing (Schwartz, 2008; Zheng and Baker, 2006). Viral replication is performed 
by high-fidelity cellular polymerases, in parallel to the replication of the cellular genome 
(Doorbar et al., 2012) under the mediation of E1, E2, E4 and E5 viral proteins. E1 and E2 are 
involved in papillomavirus replication and in intragenomic regulation, E5, E6 and E7 induce 
cellular DNA replication, E4 may represent a late function and binds to specific cytoskeleton 
structures. An important difference in the Delta-BPVs is the predominance of the E5 protein's 
activity compared to E6 and E7 in the cell cycle's disruption during a productive infection 
(Bohl et al., 2001; Silva et al., 2013). It has also emerged that intra-type sequence variation 
that occurs within papillomavirus types, can influence the cellular location and function of the 
oncoproteins and consequently affect the pathogenesis and transforming ability of the virus 
(Giannoudis and Herrington, 2001). 
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Transcription of the early and late coding regions occurs from the same strand in one direction 
only; precursor mRNAs undergo post-transcriptional processing that includes capping and 
polyadenylation of the 5´- and 3´-termini, respectively, and the papillomavirus proteins are 
produced from a myriad of alternatively spliced and polyadenylated mRNAs (Schwartz et al., 
2013). Advantages of the extensive use of alternative splicing and poly-adenylation include 
the ability to express many genes from a compact genome, as well as the ability to 
individually regulate the expression of each gene during the viral life cycle. 
Furthermore, papillomaviruses cause the depletion of intraepithelial Langerhans cells, which 
are crucial for T-cell priming (Leong et al., 2009; Matthews et al., 2003), downregulation of 
the surface major histocompatibility complex (MHC) class I, the major presenter of antigenic 
peptides to T cells (Ashrafi et al., 2006a, b), and interference with type I interferon (IFN) 
signaling (Antonsson et al., 2006; Frazer et al., 1999). As a consequence, infections often go 
unnoticed by the host also explaining the long persistence of the papillomas, even in 
immunocompetent individuals. 
  
2.2 Latency 
The latent stage of the life cycle of a virus is typified by its presence in the absence of clinical 
signs of disease. It is unclear whether HPV detection, after antibody response, reflects 
virologic clearance or establishment of viral latency (Gravitt, 2011) but it is considered likely 
that papillomaviruses cause latent infections (Broker et al., 2001; Nicholls et al., 2001; 
Stubenrauch and Laimins, 1999). In fact, PV genome can be detected in healthy skin both in 
human and animals by PCR (Antonsson e Hansson, 2002; Ogawa et al., 2004) demonstrating 
latent or subclinical infections (Antonsson et al., 2000; Astori et al., 1998; Boxman et al., 
1997) where the production of new virus particles is restricted, and the viral genome is 
maintained in a silent state with little or no gene expression. The undifferentiated proliferating 
keratinocytes, presumably stem cells, are the initial target for productive PV infections and 
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establishment of latency (Kadaja et al., 2009); however, viral genomes can also reside in 
lymphocytes, both in cattle and in humans (Campo et al., 1994a; Chen et al., 2009b). Latent 
infection of lymphocytes has also been established experimentally in cattle (Stocco dos 
Santos et al., 1998).  
Reactivation generally allows the formation of a productive infection, with or without the 
reemergence of a visible lesion (Rajcani, 2007) and seems to be related to skin trauma with 
subsequent production of inflammatory citokines and cellular proliferation. In humans, the 
high post-treatment recurrence rates of genital papillomas caused by low-risk HPV types 6 
and 11 (Lacey, 2005) and the identification of DNA and RNA transcripts in clinically healthy 
tissues of recurrent respiratory papillomatosis affected patients (Abramson et al., 2004; Maran 
et al., 1995; Pignatari et al., 1992; Smith et al., 1993) seems to support this hypothesis.  
It is difficulte to directly demonstrate establishment of latency and induction of reactivation 
from the latent state in studies involing human subjects. This has driven investigators to make 
use of animal models of infection, but the limited availability of well-characterized rodent 
models, has meant that most previous work on papillomavirus latency has focused on larger 
domesticated animals, and in particular on rabbits, dogs and cattle. 
Cottontail rabbit papillomavirus (CRPV) can induce an asymptomatic infection, characterized 
by the persistence of viral DNA in the absence of visible signs of disease (Amella et al., 1994; 
Zhang et al., 1999) with the production of E1 transcripts. The detection of viral DNA and 
RNA at regressed sites appears to be largely confined to the basal epithelial cells, and is not 
generally associated with completion of the virus life cycle and the production of new virions 
but the virus may be capable of reactivation under certain conditions (Maglannon et al., 
2011).  
Similarly, it has been suggested that canine oral papillomavirus (CPV 1) may cause a latent 
infection with DNA detected following the regression of papillomas in the absence of clinical 
signs of disease associated to low genome copy number (Stanley et al., 2001). As a mucosal 
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virus, CPV1 has been proposed as an animal model of HPV 6 and 11- associated RRP 
(Recurrent respiratory papillomatosis) in humans (Jahan-Parwar et al., 2003), CPV1 has also 
been used in vaccine development (Johnston et al., 2005; Moore et al., 2002; Stanley et al., 
2001) and immune response to infection investigations (Nicholls et al., 2001; Jain et al., 
2006). 
An ‘endogenous infection’ of the Mastomys Natalensis by the MnPV (Mastomys Natalensis 
Papillomavirus) is demonstrated by the presence of DNA at low copy number in the skin in 
the absence of clinical signs of disease. In fact, following repeated chronic mechanical 
irritation of the skin with fine glasspaper over a period of eight weeks, a 58-fold increase in 
viral DNA copy number was detected compared to non-irritated skin (Siegsmund et al., 
1991). The infection of the multimammate rat appears more interesting from a laboratoristic 
pont of view. Laboratory mice indeed provide numerous advantages as a biomedical tool over 
the current PV models in that they are relatively safe, easy to handle, and numerous 
immunological and biological reagents are readily available for detailed molecular studies 
(Ingle et al., 2011).    
The virus was demonstrated to be transmissible to immunocompetent mice; this characteristic 
made it also possible to do simple transmission studies and to investigate the pathogenesis of 
this infection and possibly determine the key genetic/protein components of resistance, 
susceptibility, and even progression to squamous cell carcinoma 
BPV entry may also result in an asymptomatic, latent infection (McBride, 2008), as it has 
been identified within BPV4-associated urinary bladder cancers (Campo, 1997; Campo et al., 
1992; Borzacchiello et al., 2003b). This viral type has also been frequently detected in normal 
bovine bladder suggesting its presence as a latent infection that can undergo reactivation when 
cattle graze on pastures rich in bracken fern (Smith, 1997) but may even be due to some other 
factors such as infection with bovine viral diarrhoea virus (Tsirimonaki et al., 2003). When 
latent BPV is activated, full malignant transformation depends on other mutagens such as 
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quercetin and ptaquiloside that act synergistically with the virus in the carcinogenic process, 
triggering BPV gene expression and leading to the development of cancer (Borzacchiello, 
2007).  
 
In horses where BPV 1 and 2 DNA can be detected in the normal skin, the occurrence of 
sarcoids at sites of skin wounding and/or following physical trauma suggests a possible 
reactivation from latency (Carr et al., 2001; Bogaert et al., 2008).  
In different species, reactivation has been correlated to exposure to ultraviolet light (Zhang et 
al., 1999), but also suppression of the adaptive immune system can lead directly to an 
elevation of the viral DNA copy number at sites of previous infection, which is consistent 
with reactivation from latency (Maglannon et al., 2014).  
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3 Interaction of Bovine Papillomaviruses with cattle   
3.1 Epidemiology  
Bovine papillomaviruses are related to serious livestock diseases causing significant 
economic losses in both beef and dairy cattle enabling the progression to cancer with or 
without the action of cofactors. Their worldwide distribution is documented by a number of 
infections in regions with a great density of cattle like Italy, United Kingdom, Germany, 
Japan, India, United States of America and Brazil (Campo and Jarrett, 1986; Ogawa et al., 
2004; Singh et al., 2009; Schmitt et al., 2010; Carvalho et al., 2012).  
Even if it is not stringent, studies on the molecular epidemiology of BPVs correlated the 
identification of the different virus types with particular tissue tropism and specific lesions.  
As a result, BPV-1 has been related to teat (Figure 6), penile and cutaneous fibropapillomas 
(Figure 7), BPV- 2 to skin warts and gastrointestinal (GI) fibropapillomas, BPV-3 to skin 
papillomas, BPV-4 to epithelial papillomas of GI tract and skin, BPV-5 to udder 
fibropapillomas, BPV- 6 to teat papillomas, BPV-7 and BPV-8 to cutaneous warts, BPV-9 
and BPV-10 to epithelial squamous papilloma lesions on cattle teats, BPV-11 to teat 
fibropapillomas and the last identified, BPV-13, has been associated with cutaneous 
papilloma of the ear (Ogawa et al., 2007; Borzacchiello and Roperto, 2008; Hatama et al., 
2011; Lunardi et al., 2012; Zhu et al., 2012; Batista et al., 2013).  
  
 Figure 6: multiple papillomatous lesions close to  
 
Figure 7: cutaneous papilloma on the lower lid of 
a cow the papillary ostium 
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Warts are detected in around one-third of cattle at slaughter (Lindholm et al., 1984), cattle of 
any age can be affected but younger animals are more prone to lesions’ development showing 
a spontaneous regression within one year (Jelínek and Tachezy 2005) due to the animal's 
immune response. Indeed, immunosuppression predisposes to PV infection progression and 
can be caused by factors such as infection with bovine viral diarrhea virus (Tsirimonaki et al., 
2003) and stress factors like gestation and lactation, to cause extensive and persistent 
papilloma formation (Munday et al., 2014). Rates of disease of upper alimentary tract 
papillomas are dependent on immunosuppressants present in bracken fern: 20% of cattle from 
geographical areas with this plant will have papillomas compared with just 4.4% of cattle 
from areas without this plant (Jarrett et al., 1978; Jensen et al., 1981). 
 
3.2 Diseases, transmission and therapy 
BPV is consequently relevant as an agent of disease in farm animals and therefore of 
considerable veterinary and agricultural importance (Campo, 2002). Papillomas tend to 
regress, but can occasionally persist and provide the focus for malignant transformation to 
squamous cell carcinoma once the virus synergizes with environmental carcinogenic co-
factors.  
Viral transmission can occur via direct or indirect contact between infected animals or with 
contaminated areas, such as milking machines, water dispensers, feeders, ropes or fences, or 
transmitted by insects (Love et al., 2012). BPV infections may start from a micro-injury, 
which exposes the peptidoglycan of heparin sulfate present in the plasma membrane 
(McBride et al., 2012). Some authors suggest that the blood can act as a reservoir for BPV 
(Freitas et al., 2003; Brandt et al., 2008) and lymphocytes can harbor the virus in the 
bloodstream (Stocco dos Santos et al., 1998; Freitas et al., 2003; Diniz et al., 2009) which can 
spread through non-epithelial tissues and fluids. Parallely to HPV, the transplacental 
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transmission of PVs appears to take place in cattle (Freitas et al., 2003; Rombaldi et al., 2008; 
Roperto et al., 2012).  
Benign neoplasm 
Warts are commonly detected in cattle and have been reported to be caused by BPV types 
belonging to the Delta, Xi, Dyoxi, and Epsilon genera (Rector and Van Ranst 2013).  
Muco-cutaneous papillomas develop on the haired skin, tongue, teats, penis, vulva and upper 
alimentary papillomas in the oral cavity, esophagus, and rumen. 
Papillomas can be experimentally induced by inoculating scarified skin with either BPV-1 or 
BPV-2 (Jarrett et al., 1990; Olson et al., 1992) but develop only at the site of inoculation, 
suggesting that any BPV DNA circulating within lymphocytes does not produce additional 
cutaneous lesions. 
BPV infection is considered necessary for the development of GI papillomas that can 
develope in every site from the mouth to the rumen, this can subsequently induce difficulty in 
feeding and breathing that may be fatal (Campo, 1997; Tsirimonaki et al., 2003; Dong et al., 
2013; Gordon, 1997). 
Papillomas and fibropapillomas on the genital area, teats (Figure 8), prepuce and penis result 
in difficulties in milking, suckling and mating, (Nasir and Campo, 2008; Jarrett,1985b). 
Usually papillomas persist for 1-6 months before spontaneous immune-mediated response 
(Knowles et al., 1996), but some animals are unable to reject the infection and succumb to 
widespread cutaneous or mucosal involvement and tumours may undergo neoplastic 
transformation. 
 Figure 8: papillomas on teats and udder in a dairy cow 
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Malignant neoplasm 
Campo (1997) demonstrated the association of BPV-4 with GI papilloma and squamous cell 
carcinoma, this discovery was subsequently supported by different findings (Campo et al., 
1980; Borzacchiello et al., 2003b). Papillomas persist and may be transformed into malignant 
carcinomas, including squamous cell carcinomas (Hamada et al., 1989; Campo et al., 1994b; 
Borzacchiello et al., 2003b; Masuda et al., 2011). 
Urinary bladder cancer comprises two main types that often occurr together in the same 
subject, carcinoma of the urothelium and hemangioendotheliomas of the subjacent capillaries.  
In general, BPV-2 has been detected in urinary bladder tumours (Borzacchiello et al., 2003a), 
and it is known to be involved in the aetiology of chronic enzootic haematuria (CEH) both in 
buffaloes and in cattle due to prolonged ingestion of bracken fern (Campo et al., 1992). In 
subjects suffering from the disease, chromosomal instability in the form of chromosomal 
aberrations was detected, confirming the synergistical action of the different component (Lioi 
et al., 2004). Interestingly, Roperto and colleagues (2012) also identified BPV-1/-2 DNA in 
the placenta of pregnant cows suffering from CEH. 
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4 Interaction of Bovine Papillomaviruses with horse 
4.1 Epidemiology of sarcoid 
Equine sarcoids are the most common dermo-epithelial skin tumors in horses and other equids 
like donkeys, mules and zebras worldwide (Jackson, 1936; Ragland, 1970; Lazary et al., 
1985; Nel et al., 2006; Bogaert et al., 2008; Nasir and Campo, 2008) with a variable 
prevalence ranging from 1 to 8% (Knottenbelt, 2005). The tumour is locally invasive, 
refractory to treatment but is often highly invasive at multiple sites and can lead to the animal 
being sacrified, with morbidity rates reported as high as 14 per 1000 horses (Campo, 2002; 
Mohammed et al., 1992). The skin of the head, ventral abdomen groin and legs of horses have 
been reported as the most commonly affected regions of the body (Jackson, 1936; Ragland et 
al., 1970, Strafuss et al., 1973, Lane 1977, Fretz and Barber 1980). A higher tendency of 
sarcoid development has been registered in regions with a hot climate (Shokry et al., 2015). In 
fact, there is strong circumstantial evidence that flies may be able to transmit BPV-1 between 
equids (Finlay et al., 2009) and it is possible that the different biting flies in different 
geographical areas have some role in the regional variations in numbers and types of sarcoid. 
Regarding lesions’distribution, in the UK it is relatively rare to find horses with single or few 
lesions, as multiple lesions (10 to several thousand) are much more common here than 
elsewhere. On the contrary, in Australia, it is less common to find horses with large numbers 
of sarcoid respect to continental Europe and North America, where an average of two or eight 
sarcoid per horse is described (Knottenbelt et al., 1995). A predisposition is observed in 
geldings (Mohammed et al., 1992) and also in males in donkeys (Reid et al., 1994; Reid and 
Gettinby, 1996). The wound is assumed as a possible entrance for BPV (Reid et al., 1994), on 
the other hand the castration wound itself is only seldom affected. However most authors do 
not assume that there is a gender predisposition for sarcoid development (Ragland, 1970; 
Miller and Campbell, 1982; Pulley and Stannard, 1990; Torrontegui and Reid, 1994). 
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Nevertheless, certain breeds and families are more vulnerable than others (Ragland et al., 
1966; Brostrom et al., 1988; Lazary, 1988; Gerber, 1989; Marti et al., 1993): in 
NorthAmerica, Quarter Horses are twice as likely to develop sarcoids compared to 
Thoroughbreds (Angelos et al., 1988). Also Appaloosas and Arabian horses are more 
frequently affected than Thoroughbreds (Angelos et al., 1988; Mohammed et al., 1992), this 
could be linked to the higher risk of these breed to get in contact with BPV working with 
cattle (Mohammed et al., 1992). Moreover, Jackson (1936) demonstrated a predilection for 
those areas of the animal's body which are frequently subjected to trauma, and specifically 
Quarter Horses and Appalossas often work on rough surfaces resulting in frequent injury to 
the limbs (Brostrom, 1995). Standardbreds on the other hand are rather resistant (Meredith et 
al., 1986; Mohammed et al., 1992; Brostrom, 1995).  
Equine sarcoids predominantly develop in young adults: the mean age of sarcoid development 
is 3.5 to 4 years (Brostrom, 1995; Studer et al., 2007), but a gradual increase in incidence is 
also observed up to the age of 15 years, followed by a decreasing incidence (Mohammed et al. 
1992). This distribution might be correlated to the acquisition of a certain level of immunity 
in adults which results in spontaneous regression of existing tumors and prevention of new 
tumor development. Another hypothesis is that genetically susceptible animals develop 
tumors early in life (Torrontegui and Reid, 1994). 
Genetic background is supposed to be involved in sarcoid epidemiology, for example, strong 
familial tendencies to sarcoid have been described (James, 1968; Marti et al., 1993). Genetic 
predisposition has been identified with over 80% of affected horses being MHC class I alleles 
(Lazary et al., 1985; Meredith et al., 1986). The genes of the MHC code for proteins involved 
in the immune response and for protein components of the complement system (Piscopo, 
1999). The suggested autosomal recessive gene responsible for imparting a susceptibility to 
the condition probably influences the severity and recurrence of the disorder in individuals.  
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4.2 Disease, transmission and therapy 
Papillomaviruses are generally considered to be highly specific for their hosts; however, 
within the Delta-PVs, BPV types 1, 2 and 13 are well recognized to infect multiple species 
causing sarcoid tumours in horses, donkeys and mules (Olson and Cook, 1951). Infections are 
also described in other distantly related mammals like buffaloes, yaks, tapirs, giraffes, bisons 
and zebras (Lohr et al., 2005; Literak et al., 2006; Kidney and Berrocal, 2008; Nasir and 
Campo, 2008; Silvestre et al., 2009; Pangty et al., 2010; van Dyk et al., 2011; Bam et al., 
2012; Kumar et al., 2013). The economic loss is important both for the racing industry and 
even more for the farmers in developing countries, for whom often the mule or donkey is the 
only livelihood.  
Although the pathology has been recognized for centuries (Erk, 1976), the term sarcoid was 
firstly used by Jackson in 1936 who described the lesion as “a unique locally invasive, benign 
neoplastic like tumour of the skin with a variable epidermal component which has a high 
propensity for recurrence”. The name itself, meaning flesh-like was used to emphasise the 
clinical and pathological differences from papilloma, fibroma, and fibrosarcoma and to 
suggest the malignant sarcomatous appearance of the lesions. However, various terms have 
been used to describe sarcoids, including warts papillomas, fibrosarcomas, schwannomas and 
recurring granulation tissue. 
Macroscopically, sarcoids show a variable appearance and have been classified in to six 
distinct clinical forms (Pascoe and Knottenbelt, 1999). Verrucous sarcoids have a typical 
wartlike appearance with a rough, thickened, scabby surface above the fibroblastic part of the 
tumor (Knottenbelt et al., 1995); nodular sarcoids (Figure 9) are subcutaneous, easily 
moveable nodules, often but not always spherical, covered by intact, apparently normal skin 
(Foy et al., 2002); fibroblastic sarcoids are large fibrous masses with an ulcerated surface; 
occult sarcoids (Figure 9) are flat circular to oval areas characterized by alopecia and a 
roughened or scaly appearance (Knottenbelt et al., 1995); malevolent (Figure 10) sarcoids 
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infiltrate in lymphatic vessels resulting in multiple nodular or fibroblastic masses along these 
vessels; mixed sarcoids are a conglomerates of two or more sarcoid types in various 
combinations. Categorization of sarcoid lesions is important because the various clinical 
forms may require different treatment approaches, and it also helps in professional discussions 
to have a common approach to the description of the various types (Knottenbelt, 2005).  
BPV DNA has been detected in up to 100% of examined sarcoid tumours (Otten et al. 1993; 
Carr et al. 2001; Martens et al. 2001a, b; Bogaert et al. 2007), with a majority of BPV1 DNA 
compared to BPV2 DNA, which may reflect geographical distribution (Angelos et al., 1991; 
Otten et al., 1993; Martens et al., 2001b; Bogaert et al,. 2007; Wobeser et al., 2010). 
Interestingly, sequence analysis of BPV DNA isolates extracted from sarcoids demonstrated 
the presence of distinct equine sarcoid-specific variants of BPV (Otten et al., 1993; Reid et al., 
1994; Chambers et al., 2003; Nasir et al., 2007). The sequence changes in the E5 protein 
reported by Reid and colleagues (1994) and Chambers and colleagues (2003) suggest the 
possibility that these changes are contributing factors to the pathogenesis of the disease. 
The predominant cell type is a malignant/transformed fibroblast but the histological 
components of the equine sarcoid can include, in variable proportions, fibroblasts, epidermis, 
and endothelial cells.  
 
 
Figure 9: occult (hairless area, left) and nodular (large 
roundbump at right) forms of equine sarcoid. Source: PaVE. 
Author: Malcom Morely. 
Figure 10: Malignant sarcoid on the abdomen of a 
horse 
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It is important to recognize that the “less severe” forms can rapidly progress to the more 
aggressive types with infiltration of surrounding skin, particularly if they are traumatized 
(Marti et al., 1993; Broström, 1995; Knottenbelt et al., 1995, 2003; Ragland, 1970).  
Generally in different sarcoid types, the epidermis varies from thick, rough and hyperkeratotic 
to thinned or ulcerated while in less typical sarcoids the epidermal component can be normal, 
atrophic or even absent (Lepage et al., 1998; Marti et al., 1993; Martens et al., 2000). 
Diagnosis of equine sarcoids can be assessed in three different ways: biopsy followed by 
histopathological analysis, which represents the definitive differentiation method but is not 
without hazard; the others are detection of BPV DNA, and clinical examination (Martens et 
al., 2000; Bogaert et al., 2008; Carr, 2009; Sala et al., 2010). The latter can be difficult to 
assess as other conditions can macroscopically be hard to differentiate from sarcoids. 
Transmission between horses and eventually from cattle to horses is still controversial. Horse-
to-horse transmission was suggested by the findings of specific BPV-1 variants in sarcoid 
lesions  which are not present in BPV-1 infections in cattle (Nasir et al., 2007); direct contact 
and rubbing have been implicated, but also vertical transmission via blood and semen of 
horses may take place (Freitas et al. 2003; Yaguiu et al. 2008). Moreover, it is believed that 
flies play a role in the transference of BPV between cattle and horses (Nasir and Campo, 
2008; Finlay et al., 2009). 
Treatment is often challenging, due to the variable clinical presentation of lesions and the 
frequent local recurrences, therefore various topical applications (Stadler et al., 2011), 
immunotherapy (Klein 1990, 1986; Theon 1998), radiation therapy (Henson and Dobson 
2004; Theon et al., 1995; Byam-Cook et al., 2006), chemotherapy (Theon et al., 1999; 
Spoormakers et al., 2003; Knottenbelt et al., 2000), cryosurgery (Martens et al., 2001c; Carr 
2009; Scott and Miller 2011), ‘traditional’ sharp surgery (Knottenbelt et al., 2000; Reschke, 
2012) and laser surgery (Diehl et al., 1987; Vingerhoets et al., 1988; Carstanjen et al., 1997), 
have all been reported in the veterinary literature and an even wider variety of nonprescription 
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treatments are used by the horse-owning public (Knottenbelt and Walker, 1994; Sonvico et 
al., 2009). Different methods have been used separately, or have been combined, with 
variable efficacy. If lesions are small and few in numbers or where they do not interfere with 
normal function it may be better not to intervene therapeutically. This also applies to cases 
considered too severe to be treated by any conventional means, but where other factors such 
as pregnancy, may be a reason for prolonging life. Therefore, vaccinations and 
immunotherapies have been also explored as they may stimulate the immune system to limit 
the viral spread. 
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II 
AIM OF THE STUDY 
 
Papillomaviridae are thought to be one of the oldest viral families that co-evolved with their 
hosts over millions of years. The viruses belonging to this species are claimed to be strictly 
species-specific and, even in experimental conditions, they do not infect any other host than 
their natural one, in this context  BPVs belonging to Delta genus represent an exception for 
their widely documented ability to infect hosts different from cattle and in particular in horses.  
The present thesis focuses on the infections of BPVs in different animal species and it was 
aimed at expanding the actual knowledge of the biology of theses viruses.  
Despite the importance of the benign and malignant tumours caused by the infection with 
bovine papillomavirus in cattle (Borzacchiello and Roperto, 2008), limited information is 
available about the distribution of the different viral types on the Italian territory. Hence, the 
objective of Paper I was the molecular characterization of the BPVs harbored in clinically-
diagnosed papillomas of cattle. The identification of a new variant of BPV type 7 in 
mammary papillomas, during the above survey, allowed to determine their entire genomic 
sequence. Details of the main genomic features and prediction of the secondary structures of 
encoded proteins are provided in Paper II. In Paper III we investigated the causes of several 
outbreaks of a malignant proliferative skin disease that affected domestic ruminants in Sicily 
during 2011–2014. With the aid of a newly developed mini array kit we showed the so-called 
“papillomatosis” can be the result of multiple infections with epitheliotropic viruses, 
including zoonotic poxviruses, that cannot be properly identified with classical diagnostic 
techniques. The results led us to suggest a further role of BPVs during co-infections with 
other epitheliotropic viruses.  
Paper IV is about a molecular investigation of a histologically classified fibropapilloma of a 
red deer shot in the Italian Alps was conducted with the objective to identify the presence of 
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PVs genomes. Increasing evidence suggests the commensalic role of PVs in humans and in 
different animal species. Consequently, in Paper V we evaluated the ability not only of Delta 
but also of the other BPVs genera to sub clinically infect species other than the host one. 
Specifically, we investigated the presence in healthy skin and mucosa of wildlife species of 
the same types detected in domestic animals. BPV types 1 and 2, give rise to sarcoids, in 
horses and donkeys, with E5 gene specific nucleotide substitutions. In Paper VI we 
investigated whether this genetic variability may be also found in BPV1 PBMC associated, of 
sub-clinically infected horses since viral DNA can be also found in the skin of healthy 
subjects and in non-sarcoid inflammatory skin conditions.  
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Abstract  
Limited information about the distribution of different Bovine Papillomaviruses (BPVs) types 
in Italy is available; therefore, this study aimed at investigate the presence of BPVs in cattle’s 
lesions in Emilia Romagna region. Sixty four proliferative lesions were analyzed by 
qualitative PCR with genus and type-specific primer pairs, as well as Rolling Circle 
Amplification (RCA). The results showed, for the first time in Italy, the presence of BPV6, 7, 
8, 10 and 12 as well as the circulation on the territory of PV types previously described in 
other European and extra European countries; in addition, the high prevalence of viral co-
infections gives new information about viral tropism.  
Keywords: Bovine papillomavirus; Co-infections; Diagnosis; Proliferative lesions; Viral types  
 
40 
Bovine Papillomaviruses (BPVs) induce hyperplastic generally regressing benign lesions of 
both cutaneous and mucosal epithelia in cattle, but the presence of environmental co- factors 
may also evolve into cancer. Wide incidence of BPVs, present as single or multiple infections 
in cattle herds in various regions of the world has been documented in literature (Schmitt et 
al., 2010; Carvalho et al., 2012), but limited information about the types circulating in Italy is 
available. In fact, the presence of the virus is mostly confirmed by clinical examination only. 
Our study aimed at identifying and characterizing BPVs in lesions in different anatomical 
sites of beef and dairy cattle from Emilia Romagna region in order to widen the knowledge 
about their distribution.  
 
A total of 64 proliferative cauliflower-like lesions, clinically identified as papillomas, were 
collected for diagnostic purposes from head (19), vulva (1) udder and teats (44), by vet 
practitioners (Table 1). After DNA extraction (Qiagen, Hilden, Germany) and quality 
assessment by bovine β-globin gene amplification, PCR (Taq DNA polymerase Qiagen) was 
firstly performed with genus-specific primer pairs and consequently with the type-specific 
ones (Table 2). Amplification was also performed by Rolling Circle Amplification (RCA; 
Illustra Templiphi kit GE, Healthcare) and subsequently digested. Purified amplicons (Roche 
Molecular Diagnostics, Mannheim, Germany) were sequenced with Sanger method (Perkin-
Elmer Applied Biosystems, Foster City, CA, USA) and chromatograms assembled (4Peaks 
1.7.1).  
 
Xi genus was identified in 50 lesions (84.7%), Delta in 31 (52.5%), Dyo-Xi in 24 (40.6%) and 
Epsilon in 2 (3.3%), while five samples tested negative for any BPV both by PCR and RCA. 
Co-infections with viral types belonging to three, two and one genus were detected in 8, 31 
and 20 samples respectively. 
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According to recent findings, stating the presence of zoonotic parapoxviruses in cow 
clinically diagnosed with papillomatosis, we tested the five BPV negative samples and found 
one positive to pseudocowpoxvirus (data not shown). Parapoxviruses cause infections that fall 
into the category of neglected zoonosis, their presence in unspecific lesions evidence the 
inadequacy of the clinical diagnosis when not supported by laboratory analyses to identify 
zoonotic agents (Scagliarini et al., 2015). 
This investigation leads to demonstrate, for the first time in Italy, the presence of BPV6, 7, 8, 
10 and confirmed the presence of types1, 2, 3 and 9. The most detected types on teats and 
udder were BPV7 (23/44), 9 (17/44) and 10 (26/44), resembling the situation described in 
Japan (Hatama et al., 2008) and Brazil (Tozato et al., 2013), but also types 1, 2, 3, and 8 were 
identified. The latter is the most commonly detected in Germany (Schmitt et al., 2010) while 
in this investigation only one sample showed positivity to BPV8. BPV3 was found to be the 
second most frequent type in cutaneous lesions in Brazil (Carvalho et al., 2012), in our study 
it was identified both in the head and in udder lesions, always in association with Delta types. 
In line with other findings (Jarrett et al., 1984), we amplified BPV6 only from mammary 
lesions. As previously reported, BPV2 was found in anatomical regions other than bladder 
and it was the most frequent type (11/19) associated with head's lesions. In this site also types 
1 (7/19), 3 (2/19), 7 (2/19), and 12 (2/19) were amplified. 
Twenty nine samples were co-infected by two types, while three-type infections had no 
preferential combinations and only 20% of samples harbored a single type. It remains a 
subject of speculation whether the presence of one BPV type will increase the likelihood of 
acquiring a second one. In addition it is unknown whether the warts are caused only by one 
type, and the other types are only passengers or whether they are both biologically active 
(Schmitt et al., 2010). Nevertheless our data suggest that when different animals in the same 
herd suffer from papillomatosis, lesions tend to manifest with the same localization, 
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macroscopic effects and same or similar combination of viral types between different 
subjects. 
None of the samples harbored types 4, 5, 11, 13 and 14. This is not surprising for BPV4, as it 
is frequently associated with papillomas of the upper alimentary canal (Borzacchiello et al., 
2003), and BPV14 which is still an uncommon finding in cattle. On the contrary BPV5, 13 
and 11 were already described in cutaneous and teat papillomas clinically resembling the ones 
observed in our study (Carvalho et al., 2012). Sequencing of BPVs belonging to Xi and 
Epsilon genera, harbored in eleven specimens, didn't allow the identification of the viral 
types. The only sample collected from a lesion, localized in the vulva, tested positive for type 
2 but it was not possible to identify the type amplified with Xi genus primer pair as a noisy 
sequencing signal was obtained from the amplicons. 
RCA amplification evidenced a limited sensitivity compared to the PCR amplification 
performed with genus and type specific primer pair, furthermore results were not always in 
accordance with PCR findings, even if in some cases RCA allowed the identification of BPV 
genomes where specific primers failed. In addition, in five samples RCA amplified an 
unknown pattern consistent with a PV genome, leading us to conclude that PCR and RCA 
need to be employed in parallel to increase the sensitivity when performing papillomavirus 
investigations.  
 
In conclusion, our results deepen the knowledge on the presence of BPVs circulating in 
Emilia Romagna region and provide new information on the presence of many different viral 
types in Italy. To the best of the authors’ knowledge, this study represents the first 
identification of the BPV types 6, 7, 8, and 10 in cattle in Italy, as well as BPV12 in Europe, 
and supports the hypothesis that these viral types are widespread. These data are considered 
necessary to develop proper prophylactic and therapeutic measures, based on the production 
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of a vaccine that may lead to a large reduction in the incidence of the diseases in animals and 
consequently in reduction of the economic losses caused by BPVs' infections. 
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Table 1- Summary of the results obtained from cutaneous and mucosal proliferative lesions collected from 
diseased cattle in Emilia Romagna region. Anatomical site of collection and results obtained by PCR and RCA 
are described. Greek letters indicate the viral genera; when in brackets, mean that it was not possible to identify 
the viral type. 
Sample 
ID 
Site of 
collection 
Genera identified by PCR 
RCA results BPV 
types 
detected 
  δ ε  ξ  
Dyo-
ξ 
 
 
180 Udder     Negative Negative 
211* Teats   X X Negative 10, 7 
212* Teats X  X X Unknown pattern 1, 9, 7 
213* Teats     Negative Negative 
215* Teats   X X BPV7 9, 7 
217* Teats X  X X Negative 1, 10, 7 
218* Teats   X X Unknown pattern 9, 7 
220* Teats     Negative Negative 
221* Teats X  X X BPV7 2, 7, (ξ) 
468 Teats   X  Negative 9, 10 
469 Udder   X  BPV10 10 
470 Udder   X  Negative 9, 10 
471 Udder   X  BPV10 9, 10 
472 Udder   X  BPV10 9, 10 
473* Udder   X  BPV10 10 
474* Udder   X  Negative 10 
475 Udder  X X  BPV9 8, 9, 10 
476 Udder   X  BPV10 9, 10 
477* Udder   X X BPV9 9, 10, 7 
478* Udder   X  BPV10 9 
479* Udder X  X  BPV9 2, 9 
480* Udder X  X  BPV9 2, 9, 10 
481* Udder   X X BPV9 9, 10, 7 
482* Udder   X X BPV6 6, 9, 7 
483* Udder   X X BPV10 9, 10, 7 
484* Udder   X X BPV10 10, 7 
507* Udder   X  BPV10 9, 10 
129* Head X    BPV1 1 
254 Vulva X  X  Negative 2, (ξ) 
465 Head     Negative Negative 
466 Head   X  Negative (ξ) 
201* Head X  X  BPV2 2, (ξ) 
202* Head X  X X Negative 1, 2, (ξ), 7 
203 Head X    Negative 1, 2 
525* Teats   X X Unknown pattern 10, 7 
526 Teats   X X Negative 10, 7 
527 Teats   X X Negative 10, 7 
528* Teats   X X Negative 10, 7 
529 Teats X  X X Negative 2, 10, 7 
530* Teats X  X X Negative 2, 10, 7 
531* Teats   X X Unknown pattern 10, 7 
532* Teats    X 
Consistent with 
BPV2/6 
7 
533* Udder  X X X Negative (ε), 10, 7 
535 Udder    X Negative 7 
536* Teats   X X Negative 10, 7 
130 Head X    BPV2 2 
170* Head X  X  BPV1 1, 3 
171* Head X  X  BPV1 1, (ξ) 
172  Head X  X  BPV1 1, 3 
173* Head X  X X BPV3 1, 3, 7 
165* Udder X  X  BPV1 1, 3 
166* Udder X    BPV1 1 
200* Udder     Negative  Negative 
175* Head X  X  Negative 1, 12 
176 Udder X  X  BPV1 1, (ξ) 
360* Udder X    BPV1 1 
388* Head X    Negative 2 
579 Udder X  X  BPV1 1, 3 
353* Head X  X  Unknown pattern 2, (ξ) 
354* Head X  X  BPV2 2, 12 
355* Head X  X  Negative 2, 3 
356* Head X    Negative 2 
357* Head X  X  BPV2 2, (ξ) 
358* Head X  X  Negative 2, (ξ) 
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PCR= Polymerase Chain Reaction; RCA= Rolling Circle Amplification; *= multiple lesion on site of collection; BPV= Bovine 
Papillomavirus 
 
Table 2 – Pimer pair used for PCR amplification of different BPV genera and types from cutaneous and mucosal 
proliferative lesions.  
Primer name, sequence and reference 
 
 
 
Amplicon 
lenght (bp) 
 
 
Annealing 
region 
(amplified 
type) 
Annealing 
temperature 
 
 
BPV 310f: 5’-RACACGGATGABTTTGTYACWCGMAC-3’ 
BPVBPV 310r: 5’-CCCARTGYTCHCCWTCRCARGG-3’ 
Brandt et al., 2011 
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L1 ORF 
(BPV3-10) 
52°C 
5’B1/2-E5: 5’-CACTACCTCCTGGAATGAACATTTCC-3’ 
3’B1/2-E5: 5’-CTACCTTWGGTATCACATCTGGTGG-3’ 
Brandt et al., 2008 
499 
(BPV1) 
497 
(BPV2) 
E5 ORF 
(BPV1, 2) 
65-56°C 
touch down 
BPV 58f: 5’-TTTTATCATGGAGAAACAGAAAGACTAC-3' 
BPV BPV58r: 5’-CAAAGCCTATRTCCATCATATCTCC-3’ 
Brandt et al., 2011 
501 
L1 ORF 
(BPV5, 8) 
63°C 
BPV 3/6f: 5’-CAGTCAATTGCAACTAGATGCC-3’ 
BPV 3/6r: 5’-GGCTGCTACTTTCAAAAGTGA-3’ 
Carvalho et al., 2012 
216 
L1 ORF 
(BPV3, 6) 
60°C 
BPV 4f: 5’-GCTGACCTTCCAGTCTTAAT-3’ 
BPV 4r: 5’-CAGTTTCAATCTCCTCTTCA-3’ 
Stocco dos Santos et al., 1998 
170 
E7 ORF 
(BPV4) 
55°C 
BPV 7f: 5’-CCACCAACGCAGCCTATTGCAAG-3’ 
BPV 7r: 5’-GGTGCACAAGACCTGTCTTCTTGC-3’ 
Brandt et al., 2011 
626 
L2 ORF 
(BPV7) 
57°C 
BPV 9f: 5’-AAAGAGCAAATCGGGAGCACC-3’ 
BPV 9r: 5’-AACTAATGACCCACTAGGGCTCC-3’ 
Carvalho et al., 2012 
264 
L1 ORF 
(BPV9) 
60°C 
BPV 10f: 5’-AAGGCATTTGTGGTCTCGAGG-3’ 
BPV 10r: 5’-CTAAAGAACCACTTGGAGTGCC-3’ 
Carvalho et al., 2012 
148 
L1 ORF 
(BPV10) 
60°C 
BPV 12f: 5’-ATAATCCAGAGAATCAGAGACTAG-3’ 
BPV 12r: 5’-GTC TTC TGG TGG TAT GCC ATC T-3’ 
Designed in our lab 
542 
L1 ORF 
(BPV12) 
53°C 
PCR= Polymerase Chain Reaction; bp= base pair; ORF= Open Reading Frame; BPV= Bovine Papillomavirus. 
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Abstract 
Two novel bovine papillomavirus type 7 (BPV-7) variants have been identified in teat 
cutaneous papillomas affecting dairy cows in northern Italy. The entire genome sequences of 
two BPV-7 Italian variants showed major sequence differences in the long control region 
(LCR) and in the L2 gene compared to the Japanese reference strain. In order to define the 
stability of these genetic variants, the L2 and LCR sequences of seven further BPV-7 positive 
isolates were characterised. An insertion of 6 amino acids in the L2 structural protein has been 
detected in all samples while different genetic variants have been identified for the LCR. 
These findings provide new insights on intra-type variability of bovine papillomaviruses and 
represent a starting point for future studies aimed at establishing the biological role of the 
different BPV genomic regions and investigating the pathogenic potential of papillomavirus 
variants.  
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Introduction  
According to de Villiers and colleagues [1], bovine papillomaviruses (BPVs) responsible for 
bovine infections are classified in four genera: Deltapapillomavirus (BPV-1/2/13), 
Epsilonpapillomavirus (BPV-5/8), Xipapillomavirus (BPV-3/4/6/9/10/11/12) and 
DyoXipapillomavirus (BPV-7). 
Genome organization of BPVs is similar to other papillomaviruses consisting of a single 
molecule of circular double-stranded DNA that encodes 8 to 10 proteins. The whole genome 
can be divided into three parts with different functions: a long control region (LCR) that 
regulates transcription and contains the origin of replication, the early (E) region that contains 
open reading frame (ORF) for replication, transcription and transformation and the late (L) 
region that contains the ORFs encoding the two structural proteins combined in the viral 
capsid. 
Bovine papillomatosis is an infectious disease distributed worldwide among herds which 
causes hyperproliferative lesions of skin and mucosae. According to viral type and different 
environmental co-factors, BPVs can induce cutaneous papilloma (BPV-1, -2, -8), cancer of 
the upper gastrointestinal tract (BPV-4), cancer of the urinary bladder (BPV-1 and -2), and 
papillomatosis of teats and udder (BPV-1, -5, -6, -7, -9, -10, -11). Fibropapillomas and 
papillomas of teats and udders have important economic impact, as the local viral spread can 
be so extensive that cows milking may become difficult or impossible [2].  
Bovine papillomavirus type 7 was originally isolated in Japan from cutaneous papillomas and 
healthy teat skin samples by Ogawa and colleagues [3], and it was classified in the novel 
DyoXi Papillomaviridae genus. Subsequently Tozato et al., [4] detected BPV-7 in Brazilian 
dairy herds affected by teat papillomatosis. 
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Limited information are available on the viral BPV types circulating in Italy, on this basis 
during a biomolecular screening of BPVs variety affecting cattle herds of Emilia Romagna, 
BPV-7 was detected for the first time. The aim of the study was to perform genomic 
characterisation of 9 BPV-7 samples causing teat papillomas in dairy cows.   
 
Materials and methods   
In order to evaluate the diffusion of cutaneous papillomaviruses in dairy herds from Emilia-
Romagna (Italy), a molecular survey was conducted by amplifying the L1 gene using the 
primers FAP59/FAP64, as described by Forslund et al., [5] and subsequently sequencing the 
obtained 480 bp  product. 
DNA from nine BPV-7 positive samples was amplified by multiple-primed Rolling-Circle 
Amplification (RCA) using the Illustra TempliPhi 100 amplification kit (GE Healthcare, 
Little Chalfont, UK) following the protocol previously described by Rector et al., [6]. A 
digestion with restriction enzymes BamHI and Hind III was subsequently performed and 
products were run on a 0.8% agarose gel to confirm the presence of DNA fragments 
consistent with the length of a papillomaviral genome. RCA positive DNA products were 
precipitated in ethanol to remove salts and residual enzymes and sequenced by primer 
walking with an original set of primers manually designed (Supplementary table S1, 
Supplementary material). Sequencing was performed with an ABI Prism 3100 Genetic 
Analyzer (Perkin-Elmer Applied Biosystems, Foster City, CA, USA) using a DNA 
concentration of 800 ng per sample. Electropherograms were inspected and edited with 
4Peaks 1.7.1, and contigs were obtained with SeqMan II (DNASTAR, Madison, WI, USA).  
The whole genome sequences of samples 215 and 221 were deposited in the GenBank using 
the National Centre for Biotechnology Information (NCBI, Bethesda, MD) BankIt v3.0 
submission tool (http://www3.ncbi.nlm.nih.gov/BankIt/) under accession numbers KM096428 
and KM096429, respectively. 
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Genomes open reading frames were investigated by using the ORF Finder tool on the NCBI 
server of the National Institutes of Health (http://www.ncbi.nlm.nih.gov/gorf.html). 
Transcription factor binding sites and motifs were searched either manually or online using 
ScanProsite (http://www.expasy.ch/prosite). 
A prediction of the secondary structures of the L2 proteins of the 215 and 221 Italian variants 
and BPV-7 reference strain (NC_007612) was obtained by using the PSIPRED v3.3 software 
of the PSIPRED Protein Sequence Analysis Workbench (http://bioinf.cs.ucl.ac.uk/psipred/) 
[7], and the open resource for online prediction of protein structural and functional features 
PredictProtein [8].   
The complete sequences of the BPV-7 215 and 221 variants were aligned with other 95 PVs 
at the amino acid level using ClustalW (Supplementary table S2, Supplementary material). 
Alignment included the concatenated regions E1, E2, L1, L2, as in García-Pérez et al., [9]. 
The evolutionary history of the two BPV-7 variants and the 95 further PVs was inferred by 
using the Maximum Likelihood method based on the LG + freqs (+F) amino acid model [10], 
identified as the best-suited evolutionary model for our data. Initial tree(s) for the heuristic 
search were obtained automatically by applying Neighbor-Join and BioNJ algorithms to a 
matrix of pairwise distances estimated using a JTT model, and then selecting the topology 
with superior log likelihood value. A discrete Gamma distribution was used to model 
evolutionary rate differences among sites (5 categories (+G, parameter = 1.1032)). The rate 
variation model allowed for some sites to be evolutionarily invariable ([+I], 6.3027% sites). 
The analysis involved 97 amino acid sequences. All positions containing gaps and missing 
data were eliminated. There were a total of 1076 positions in the final dataset. Evolutionary 
analyses were conducted in MEGA6 [11]. 
To investigate the most variable regions of the BPV-7 genome, specific primers for the 
amplification of a portion of the L2 and LCR ORFs were manually designed according to the 
alignment of the BPV7 Italian variants 215 and 221 with NC_007612 BPV-7 (Supplementary 
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table S3, Supplementary material). PCR amplifications of strains 202, 217, 218, 525, 531, 
532, 535 representing 7 additional BPV-7 Italian isolates, were performed in a 50 l volume 
containing 20 M of each of the appropriate primers, according to Qiagen recommendations 
for Taq polymerase. Cycling conditions for L2 amplification were as follows: denaturation at 
94°C for 5 minutes followed by 35 cycles of 94°C for 30 seconds, 58°C for 30 s, 72°C for 45 
s and a final extension of 72°C for 5 minutes. Cycling conditions for amplification of a 
portion of the LCR were as follows: 94°C for 5 minutes followed by 35 cycles of 94°C for 30 
seconds, 52°C for 30 s, 72°C for 45 s and a final extension of 72°C for 5 minutes. PCR 
products were purified using the High Pure PCR Product Purification Kit (Roche) following 
manufacturer recommendations and directly sequenced using both the forward and reverse 
primers. Sequencing was performed on an ABI Prism 3100 Genetic Analyzer (Perkin-Elmer 
Applied Biosystems, Foster City, CA, USA) and sequences analysis end editing were 
obtained by 4Peaks 1.7.1 (Griekspoor and Groothuis, mekentosj.com) 
 
Results 
During a survey conducted to evaluate the diffusion of cutaneous papilloma in dairy 
herds from Emilia-Romagna (Italy), nine animals from 2 different farms were found infected 
with BPV-7 (Table 1). 
Genomic characterisation of BPV-7 positive samples was achieved by RCA combined to 
BamHI and HindIII digestions, which led to the generation of a pattern consistent with the 
presence of a papillomavirus genome in 3 out of 9 samples (215, 218, 221). In particular 
BamHI produced a single fragment of approximately 8 Kb in the samples 215, 221, and 218, 
while digestion of samples 215 and 221 with Hind III generated four fragments of about 1 Kb, 
1.3 Kb, 2 Kb and 3 Kb, consistent with the size of BPV-7 viral genome. Gel electrophoresis 
of HindIII digested 218-RCA products showed the presence of fragments of unexpected size, 
8 Kb, 5 Kb, 3 Kb, 2,5 Kb that may be attributable to a mixture of papillomaviral DNA. Direct 
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sequencing of the RCA amplicons allowed to obtain clear sequences of the 215 and 221 entire 
genomes, while chromatograms relative to the 218  sample were very disturbed with 
overlapping peaks along all the sequences. ORF analysis of the 215 and 221 genome 
sequences showed the presence of the seven classical PV major ORFs, encoding for five early 
(E), two late (L) proteins, and of a LCR. Nucleotide and amino acid identities of the single 
ORFs with BPV-7 reference strain (GenBank n. NC_007612) are showed in Table 2. The L1 
ORFs of the Italian variants showed nucleotide and amino acid identities of 99,5% and 99,8%, 
respectively, with BPV-7 reference strain and therefore, according to the criteria proposed 
from De Villiers and colleagues, [1], they can be classified as BPV-7 variants. 
Complete genomes of the 215/221 BPV type 7 Italian variants consist of 7438 and 7526 bp, 
respectively, and nucleotide similarity with BPV-7 reference strain NC_007612 is 97,9% 
(215) and 98,8% (221). According to the ICTV Papillomavirus Study Group, viruses of the 
same type showing more than 1.0% nucleotide sequence divergence in the whole genome, 
should be classified as distinct variant lineages. Consequently, strains 215 and 221 can be 
classified as BPV type 7 variant lineages B1 and B2. The different genome length of the two 
BPV- 7 variants was due to in frame deletions and insertions in the L2 ORF, and in the 
untranslated LCR. In particular, BPV-7 221 showed an insertion of 18 nucleotides (6 amino 
acids, VLRPDE), at nucleotidic  position 459 of the L2 ORF while the BPV-7 215 had a 
deletion of 108 nucleotides causing the lack of  36 amino acids in the same position.  The 
LCRs of both 215 and 221 variants host an insertion of 156 and 118 nucleotides respectively 
consisting in the duplication of two sequences of 26 and 33 nucleotides respectively at the 
same position.  
Sequence analysis of the complete genome of the Italian variants allowed to establish the 
presence the canonical motifs previously identified in the BPV-7 reference strain, and of 2 
additional polyadenylation signals in the E1 and L2 ORFs (Table 3). The L2 amino acid  
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sequences of BPV-7_215 and BPV-7_221  contain most of the protein interactions domains 
and features conserved in all PV types, such as: Proline residues (PxxP) associated with 
protein-protein interaction, two highly conserved cysteine residues (C22 and C28), the 
consensus furin cleavage motif site (R-X-K/R-R) conserved at around amino acids 9-12 [12], 
and the transmembrane like domain region at its N-terminus that includes several highly 
conserved GxxxG motifs. 
The prediction of the secondary structure of the two BPV-7 variants indicated that L2 has two 
alfa helix regions at the amino-terminus part of the protein followed by a different number of 
beta-sheets. The insertion and deletion found in the L2 proteins of the 221 and 215 BPV-7 
variants fall in a region of the L2 protein predicted as a coil exposed at the surface of the 
protein.  
Sequence variations detected within the L2 ORF and LCR of BPV-7 215 and 221 were 
investigated for the 7 additional BPV-7 strains found in teats papillomas. Sample 218 showed 
the same 108 nucleotides deletion already detected in the L2 ORF of sample 215, while the 
samples 202, 217, 525, 531, 532, 535 had the 18 nucleotides insertion identified in the L2 
ORF of sample 221. Four variants of the LCR regions were identified. None of the 4 variants 
was identical to the reference sequence. Sequence of strain 202 showed 100% identity with 
strain 221, and 218 showed 100% identity with strain 215. Strain 217 showed an insertion of 
37 nucleotides containing the same duplication of 26 nucleotide identified in variants 215 and 
221 (Supplementary figure S1, Supplementary material). Samples 525, 531, 532, and 535 
showed an insertion of 142 nucleotides containing three additional E2 binding sites 
(Supplementary figure S2, Supplementary material).  
The phylogenetic trees were obtained from a concatenated E1/E2/L1/L2 amino acid alignment 
of isolates 221and 215 with 95 PV-types representative of the different PV genera and species 
(Figure 1). The resulting maximum likelihood phylogenetic trees clustered the PVs in their 
respective genera, according to the new PV classification [13]. Also, the main genera 
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associations previously observed [14; 15] were maintained. In particular, the Delta, Epsilon, 
and Dyokappa viruses, infecting Artiodactyla, grouped together with the PVs infecting 
Equidae (Zeta, Dyoiota, Dyorho, and EaPV1). Phi papillomavirus, infecting Capra hircus 
grouped with the bovine Xi viruses, while BPV-7 (Dyoxi) clustered in a heterogeneous group 
comprising human (Gamma) and animal papillomaviruses (Pi, Tau). As expected, the 215 and 
221 strains grouped together with the reference BPV-7 in Dyoxi papillomaviruses. The main 
clusters were statistically significant and generally supported by bootstrap values greater than 
80%. 
Discussion 
Bovine papillomatosis can be responsible of severe economic losses especially in 
dairy farms. Papillomas in teats and udders hamper cow milking, and can promote secondary 
infections leading to mastitis. To date, different papillomavirus types and genera have been 
identified as causative agents of papillomas affecting teats and udder [4; 16; 17; 18] 
BPV-7 was firstly found in diseased and healthy teat skin samples by Ogawa and colleagues 
[3], who suggested its classification within a new papillomavirus genus. BPV-7 ability to 
induce cutaneous papillomas in teat skin was further demonstrated by Tozato and colleagues 
[4]. In this study, nine samples collected from teat skin lesions of dairy cows housed in two 
distinct farms of Emilia-Romagna region, were found to be infected with BPV-7 by PCR.  
Direct sequencing of the entire genome starting from RCA products was feasible only for two 
viral strains. This result could be due to the presence of more than one type of papillomavirus 
in the samples and to the presence of genomic DNA or other confounders DNA that increased 
background amplification [19]. RCA is based on the use of random hexamers allowing to 
amplify virtually all the circular DNA molecules harboured in the skin samples such as 
bacterial plasmids and circular DNA of bacteriophages leading to competitive inhibition of 
the amplification of the viral genomes and a specific electrophoresis pattern. Similarly, in this 
study, RCA reactions of sample 218 amplified a mixture of PV DNAs showing an ambigous 
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electrophoretic pattern after HindIII digestion. Seven out of 9 samples analysed in this study 
were found to harbour more than one type of papillomavirus, such as BPV1-2-9-10 (data not 
shown). Co-infections with different types of BPV have been already reported in the same 
lesion and in healthy skin samples [4;16 ;17; 20]. The presence of multiple BPV types in 
healthy or diseased skin is reminiscent of what has been observed in human skin, where 
different human papillomavirus (HPV) can generate co-infections and are detected frequently 
at very low copy numbers [21]. The phylogenetic analysis, performed on the concatenated 
genes E1, E2, L1, L2 of 97 viral types including the Italian BPV-7 variants, gave similar 
results to those obtained by Ogawa and colleagues [3]  confirming that BPV-7 belongs to a 
novel genus whithin the family Papillomaviridae. The phylogenetic tree constructed with the 
97 PVs' concatenated ORFs was similar to those obtained with L1 gene sequences, further 
confirming the reliability of PV classification based on this ORF only.  
The deletions and the insertions found within the L2 and LCR ORFs of the Italian variants 
BPV-7_215 and 221 variants are consistent with previous findings in different papillomavirus 
types identified in Arctiodactyla. In Cervus elaphus papillomavirus type 1 a deletion of 14 
nucleotides in the untranslated LCR region and one deletion of 9 nucleotides in the L2 ORF 
were identified compared to Capreolous capreolus papillomavirus type 1, despite to the fact 
that these viruses belong to the same type and genus [22]. A 129 bp deletion in E1 was 
detected in a BPV type 10 strain associated with a mucosal tongue papilloma in a cow, 
whereas previously this BPV type has been only associated with cutaneous papillomas [23]. A 
deleted BPV-12 circular genome (E1, E2, partial E7 and L2 ORFs) was detected in an 
epithelial papilloma of a bovine, together with a full-length BPV-12 genome [24]. Genomic 
rearrangements have been also detected in human papillomavirus and correlated to 
malignancy. As an example, duplications and re-arrangements in the LCR have been found in 
HPV-6 and  -11-associated malignancies [25; 26]. Analyses of the modified LCR region, by 
functional assays, suggested that activity of this regulatory region was in some cases 
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enhanced [27] while in others, insertions and duplications did not influence the protein 
expression [28]. For this reason, whether the genetic BPV-7 variants possess distinct 
biological properties in vivo, remains to be determined. 
The L2 and LCR ORFs of nine BPV-7 isolates have been partially sequenced in order to 
establish their genetic variability.  
L2 is the major structural protein that composes the viral capsid, its configuration in native 
virions remaining partly unknown. The domains and functions of L2 appear to be well 
conserved across Papillomaviridae as the protein has a complex and multifunctional role in 
the biology of all PVs, notably in virion assembly and early events of infection [29]. 
All the L2 ORFs sequenced showed an insertion of 18 nucleotides compared to the L2 of the 
BPV-7 reference strain suggesting that this sequence variant is stable and frequent in the 
Italian BPV-7 variants. The deletion of 36 amino acids was detected only in samples 218 and 
215, collected in the same farm, leading to speculate that these BPV-7 isolates represent 
abortive infections despite to the fact that both animals showed clinical lesions.  On the other 
hand 218 and 215 samples were found co-infected with other BPV types that could be the real 
causative agents of the disease. The deletion is in fact located in a predicted loop of the L2 
protein. To a certain extent, loops are known to be flexible secondary structures that can 
tolerate variation, but in most of the cases, for instance when catalytically active residues are 
present in these structures or when they adopt important positions for protein fold, a deletion 
could interact with the structural and functional role of the protein [30]. Further studies with 
virus-like particles (VLPs) and pseudovirion assays will be necessary to verify if the deletion 
and insertion detected in the L2 BPV-7 variants may affect viral entry and DNA 
encapsidation.  
Currently there aren’t commercial VLP-based vaccines for use in animals. Vaccination 
studies in animal challenge models with L2 or part of it produced in bacteria, showed the 
production of neutralizing antibodies for a wide spectrum of PV types [31; 32; 33] for this 
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reason L2 has been  considered a good candidate to constitute a PV vaccine in animals. 
Moreover, the N-terminal of the L2 protein is highly conseved in all PVs type and includes 
regions that are recognized by neutralizing antibody [34; 29]. Our findings evidenced intra-
type variability of BPV-7 L2, and further studies on variants will clarify the consequences of 
the amino acid deletions on the antigenicity and will add information on functional motifs of 
this PV structural protein. 
Less conserved regions of the genome, such as the LCR region, are useful to identify genetic 
variants and are therefore considered informative also for phylogeographic analysis [35]. The 
LCR regions of PV contains the origin of replication and enhancer elements that are 
responsive to cellular factors as well as to virally encoded transcriptional regulatory proteins 
like E2, which is also required for DNA replication. This region plays an important role in the 
pathogenesis and transformation activity of PV because it functions as the transcriptional 
control unit of the virus. Previous studies have shown that intra-type sequence variation 
within the LCR is frequent and, in some cases, it alters the transcriptional activity, and may in 
turn influence pathogenesis and transformation [36; 35]. In our study we found 4 different 
LCR sequence variants. Genomic modifications were independent from the site of isolation 
and the features of the lesions which was apparently similar in all samples. The variant 
carrying an insertion of 142 nucleotides, leading to 3 predicted additional E2 binding sites, 
was the most frequent (4/9 samples), this may suggest an enhanced transcription activity in 
insertion's carriers. 
 
Conclusion 
For detailed and refined scenarios of PV diversification, increasing insights into the 
representativeness of each PV type are needed to better understand their evolution [37]. 
Despite the exponential increase of completely characterized animal papillomavirus genomes 
observed over the last decades, very little is known about intra-type variability, as a single 
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genome for each animal papillomavirus type is usually sequenced. In fact, differently from 
HPV, there is a limited availability of sequenced non-human PV types, subtype and variants.  
In light of this, the data obtained from this study further contributes to a better understanding 
on intra-genus variability of bovine papillomaviruses. The biological significance of the L2 
and LCR insertions and deletions, identified in the Italian BPV-7 variants, need to be further 
investigated.  
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Table 1: Samples collected and sequenced during this study 
 
sample n° Farm  sequence 
202 (GenBank KU351286 and KU351279) Farm1 portion of L2 and URR sequenced 
215 (GenBank KM096428) Farm 2 complete genome sequenced 
217 (GenBank KU351287 and KU351280) Farm 2 portion of L2 and URR sequenced 
218 (GenBank KU351288 and KU351281) Farm 2 portion of L2 and URR sequenced 
221 (GenBank KM096429) Farm 2 complete genome sequenced 
525 (GenBank KU351289 and KU351282) Farm1 portion of L2 and URR sequenced 
531 (GenBank KU351290 and KU351283) Farm1 portion of L2 and URR sequenced 
532 (GenBank KU351291 and KU351284) Farm1 portion of L2 and URR sequenced 
535 (GenBank KU351292 and KU351285) Farm1 portion of L2 and URR sequenced 
 
 
Table 2 Predicted amino acid and nucleotide features of the three BPV-7 viruses 
 
 BPV7_215 
KM096428 
BPV7_221 
KM096429 
BPV7 
NC_007612 
 
genome size 7438bp 7526bp 7412bp 
 
GC content 45,71% 48,88% 45,53% 
 
polyadenylation signal 
(AATAAA) 
1369-1374 (E1) 
4056-4061 (L2) 
5250-5255 (L2) 
5802-5807 (L1) 
6981-6986 (LCR) 
7373-7378 (LCR) 
1369-1374 (E1) 
4056-4061 (L2) 
5376-5381 (L2) 
5928-5933 (L1) 
7107-7112 (LCR) 
7456-7461 (LCR) 
 
4077-4082 (L2) 
5931-5936 (L1) 
7110-7115 (LCR) 
7342-7347 (LCR) 
E2 binding sites 
ACC(N5-7)GGT 
 
45-56 (LCR) 
3118-3129 (E2) 
7000-7011 (LCR) 
7041-7053 (LCR) 
7407-7417 (LCR) 
45-56 (LCR) 
3118-3129 (E2) 
7126-7137 (LCR) 
7167-7179 (LCR) 
7495-7505 (LCR) 
45-56 (LCR) 
68-81 (LCR) 
3118-3129 (E2) 
7129-7140 (LCR) 
7170-7182 (LCR) 
7215-7226  (LCR) 
7381-7391 (LCR) 
 
binding site for nuclear factor 1 
(TTGGCA) 
1682-1687 (E1) 
3001-3006 (E2) 
3519-3524 (E2) 
4824-4829 (L2) 
6022-6027 (L1) 
7097-7102 (LCR) 
1682-1687 (E1) 
3001-3006 (E2) 
3519-3524 (E2) 
4950-4955 (L2) 
6148-6154 (L1) 
7223-7228 (LCR) 
1682-1687 (E1) 
3001-3006 (E2) 
3519-3524 (E2) 
4953-4958 (L2) 
6151-6156 (L1\) 
7226-7231 (LCR) 
 
Predicted amino acid features 
 
TATA box like sequence 
 
57-63 (LCR) 57-63 (LCR) 57-63 (LCR) 
zinc binding domain in E6 
CxxC(x29)CxxC  
 
99-135 99-135 99-135 
LxCxE  in E7 
 
not present not present not present 
zinc binding domain in E7  
CxxC(x32)CxxC in E7 
59-98 59-98 59-98 
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Fig. 1 Electrophoresis of RCA products after BamHI and HindIII digestion. Lane M 1 kb DNA ladder (New 
England Biolabs). BamHI produced a single fragment of approximately 8 kb and HindIII generated four 
fragments of about 1, 1.3, 2 and 3 kb in both samples 215 and 221. 
 
 
 
 
Fig. 2 Genomic map of the BPV-7 Italian variants 215 and 221. The ORFs are depicted as rectangle. The 
deletion/insertion compared to the reference BPV-7 strain are indicated as vertical lines inside the rectangles. 
Arabic numerals indicate genome’s nucleotide positions. The table shows the nucleotide and amino acid (aa) 
percent identities between the BPV-7 reference virus and the new BPV-7 variants. 
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Fig. 3: Well-resolved Maximum Likelihood tree including BPV-7_215, BPV-7_221 and 95 PV-types 
representative of the different papillomavirus genera and species. ML tree of the 95 PVs was inferred by using a 
combined E1–E2–L1-L2 amino acid sequence analysis. PV genera are indicated in Greek letters and according 
to the PAVE website (http://pave.niaid.nih.gov). Branch lengths are drawn to scale. Numbers on branches are 
ML bootstrap support values. Only values above 70 are shown. 
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Abstract 
 
A mini-array test, for the rapid detection of poxviruses in animals and humans, was developed 
within the FP7 POC4PETS project. The method is based on detection that combines target 
nucleic acid amplification by PCR and specific hybridization, using enzyme-linked 
antibodies, allowing the multiple identification of zoonotic orthopoxviruses and 
parapoxviruses in animals and humans' biological samples. With 100% specificity, the test 
rules out the possibility of cross-reactions with viral agents causing look-alike diseases. The 
assay was employed on the field to investigate the causes of several outbreaks of a malignant 
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proliferative skin disease that affected domestic ruminants in Sicily during 2011-2014. Due to 
the aspect of the lesions, the animals were clinically diagnosed with papillomatosis. The mini-
array test allowed the identification of co-infections caused by more than one viral species 
belonging to the Parapoxvirus and Orthopoxvirus genera, either in goats or in cattle. The 
study suggests that the so-called "papillomatosis" can be the result of multiple infections with 
epitheliotropic viruses including zoonotic poxviruses that cannot be properly identified with 
classical diagnostic techniques. 
Keywords: diagnosis; epitheliotropic virus; mini-array test; papilloma; Parapoxvirus; 
Orthopoxvirus 
  
The families Papillomaviridae and Poxviridae include a number of viral species affecting 
different mammalians. The family Papillomaviridae (PV) now comprises 32 genera
21
 several 
of which infect ruminants. In ruminant species, papillomaviruses induce hyperplastic benign 
lesions of both cutaneous and mucosal epithelia that generally regress, but may also 
occasionally persist with the possibility to evolve into cancer in the presence of environmental 
carcinogenic co-factors. In the Poxviridae family, the genera Parapoxvirus (PPV) and 
Orthopoxvirus (OPV) include viruses that cause skin lesions in domestic and wild ruminants 
as well as in humans. The parapoxviruses: Orf virus (OV), Bovine papular stomatitis virus 
(BPSV), Pseudocowpoxvirus (PCPV) and the orthopoxviruses: Vaccinia virus (VACV) 
Cowpoxvirus (CPXV) infect via damaged skin and give rise to proliferative and/or ulcerative 
lesions of the skin and mucosae. Papillomavirus and poxvirus infections recognize the same 
risk factors in fact, being caused by highly resistant agents, they do not necessarily need a 
direct contact between infected and susceptible host to be transmitted. The shed scabs, or 
necrotic skin or mucosal tissue, contain high titres of stable viruses which can remain 
infectious long enough to sustain indirect transmission. 
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Both papillomaviruses and poxviruses infections in animals are usually diagnosed 
symptomatically and only on occasion a laboratory confirmation is requested. In fact, the 
clinical signs are considered typical, however the lesions can be easily confused with those 
shown by other diseases of ruminants such as those caused by FMDV, BTV, SPXV, CPXV. 
Early recognition of the etiologic agents allows proper control measures and disease 
management strategies, to prevent diseases spread among animals and humans in case of 
zoonotic viruses. At present, there are no routine diagnostic tests for poxviruses and this can 
lead to the possibility of mis-diagnosis with other epitheliotropic pathogens
14
. Poxvirus 
zoonoses fall into the category of neglected zoonoses, and their incidence in animals and 
humans is often unknown or greatly underestimated. In humans, under-reporting leads to 
underestimating the true number of DALYs (Disability-adjusted life year), which can be 
averted by an effective control. The availability of highly specific and sensitive diagnostic 
assays, is considered critical to perform an accurate differential diagnosis and to 
understand the real incidence and prevalence of zoonotic poxviruses among mammals
14
. The 
aim of the study was to identify, through classical and innovative diagnostic methods, the 
viruses responsible for a number of outbreaks of a disease characterized by massive cutaneous 
lesions in domestic ruminants in Sicily. The clinical diagnosis was generically defined as 
"papillomatosis" since the animals were showing multiple tumour-like lesions disseminated 
on the entire body (Fig.1a). In many cases, the symptoms were characteristic of a systemic 
disease with anorexia, lethargy and death, due to starvation, in the most severely affected 
animals. Pathological samples (Table 1) consisting in scabs and proliferative lesions, were 
submitted for standard histopathological examinations and negative staining electron 
microscopy
12
. Histopathology mainly identified hyperkeratosis and acanthosis of the 
epidermis and proliferation of the fibroblasts, consistent with fibropapillomatosis, in cows, 
while degenerative changes in the stratus spinosum, epidermal hyperplasia, hyperkeratosis, 
ballooning and degeneration of keratinocytes with eosinophilic inclusion bodies, were mainly 
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evidenced in the lesions of sheep and goats (Fig. 1b, c). Negative staining Electron 
Microscopy (nsEM) leaded to the identification of Papillomavirus particles in the samples 
collected from diseased cows and Parapoxvirus virions in affected small ruminants. Viral 
DNA was extracted from the pathological specimensa and analysed by rolling circle 
amplifications
b
 followed by restriction enzyme digestions, as previously described19, to 
characterize the papillomavirus (BPV) circular DNA. Different sets of primers3,4 have been 
used to further characterise the identified PV types. The DNA samples, purified from the 
lesions of all the diseased ruminants, were further analysed using a newly developed mini-
array assay developed within the FP7 POC4PETS project. This assay allows the identification 
of different zoonotic poxviruses, belonging to the genera Parapoxvirus and Orthopoxvirus, 
within the same sample. The test is based on a detection approach that combines target 
nucleic acid amplification by PCR and specific hybridization to probes spotted on a mini-
array. The assay, versus standard PCRs, showed 100% specificity, 87% sensitivity and a limit 
of detection of 1 fg of viral DNA. The mini-array has numerous advantages over other 
molecular diagnostic tools such as a straightforward interpretation, allowed through one step 
multiple-detection of the hybrids, which yields coloured spots on the mini-array, visible to the 
naked eye. The principles of the test are briefly described here: for the multiple detection of 
orthopoxviruses and parapoxviruses, two target genes: HA, encoding the haemagglutinin, and 
B2L, encoding the major envelope protein, have been selected for OPV and PPV respectively. 
The cytochrome C oxidase subunit I (COX I) gene, of different animal species, including 
sheep, goat, cow, horse, dog, cat and human, was also selected as internal control. 
Oligonucleotide primers for targets and probes amplifications, were designed using 
Primer3Plus
c 
web tool
25
 and OligoAnalyzer
d
 3.1 software. To allow multiplex amplifications, 
for each target gene the best primers candidates for probes and targets have been defined as 
well as the optimal PCR conditions (based on amplicon yield, specificity, sensibility, no false 
positive). Specific probes of OPV, PPV and positive control were obtained by PCR 
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amplification with FastStart Taq DNA Polymerase
e
 .Mini-arrays were then generated by 
dotting the double-stranded DNA probes onto a positively charged nylon membranef using an 
arrayerg and denaturing the DNA probes by incubation of the membrane in NaOH solution. 
Then, membrane was prehybridized in hybridization buffer containing 1% skimmed milk and 
dried. Targets are thus labelled during multiplex PCR by incorporating digoxigenin-11-dUTP
h 
with FastStart Taq DNA Polymerase. The subsequent detection assay consists of a target-
probe hybridisation step followed by a colorimetric revelation of the hybrids using enzyme-
conjugated anti-digoxigenin antibody
i
, producing a dark blue precipitate in presence of 
appropriate substrate, (Fig. 2). The mini-array analyses, performed on the DNA purified from 
all the diseased ruminants, lead us to confirm that all the sheep and goats were infected with 
PPV. Seven out of twelve cows, previously found positive for different BPV types using RCA 
analysis, were also found co-infected with parapoxviruses (Table 1). Surprisingly, two goats 
from Messina Province and two cows from Ragusa Province, showed a co-infection with 
Parapoxvirus and Orthopoxvirus (Table 1). To further characterise the poxviruses identified 
by the mini-array test, the viral DNA was subsequently amplifiedj by PPPI and PPPIV 
primers targeting the Parapoxvirus B2L gene as previously described
15
. PCR amplification of 
the OPV's DNA was performed using the primers rpo f2 5' ATG TCG AGC TTT GTT ACC 
AAT 3' and rpo r2 5' TGC CAT AGT ATT CGT GTT TATACT 3'
l
 targeting the highly 
conserved Rpo 18 gene that encodes the DNA dependent RNA polymerase of 
Orthopoxviruses (OPV)
2
. Thermal cycler conditions were set with an initial denaturation at 
94°C for 5 minutes, followed by 40 cycles of denaturation at 94°C for 30 seconds, annealing 
at 53°C for 30 seconds and extension at 72 °C for 45 seconds and a final extension at 72°C for 
10 minutes. The PCR, performed on the mini-array positive samples, lead to the amplification 
of specific fragments of 495 bp and 526 bp respectively for the B2L gene of PPVs and Rpo 18 
gene of OPVs. The amplified products were subsequently purifiedk and sequenced
l
. Sequence 
analysis of the PCR products lead us to identify BPSV in three cows and PCPV in four 
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animals, while sheep and goats were shown to be all infected with OV. The Rpo 18 nucleotide 
sequences were aligned using ClustalWm with previously published OPV sequences from 
GenBank, showing an identity ranging from 97.3% to 100% among the four OPVs detected in 
the Sicilian outbreaks. The alignments performed, with published OPV sequences, showed a 
nucleotide identity ranging from 99.6% to 100% between 9605-425, 14647-429, 33225-498 
and CPXV strain UK2000_K2984 (id. HQ420900). At the amino acid level, a complete 
identity was detected with multiple CPXV and VACV strains. A similarity of 98.1% and 
98.8%, at nucleotide and amino acid level respectively, was detected between the strain 
32063-501 and CPXV EleGri07/01 (id. KC813507). Phylogenetic trees were generated by the 
neighbour-joining method21 with 1000 bootstrap replicates10 using the Tamura 3-parameter 
model
22,23,n
. These analyses evidenced that the four OPV strains cluster into two distinct 
groups (Fig. 3). To determine the viability of viruses in samples, 60% confluent Vero 
monolayers were inoculated with 10-fold dilutions of sonicated tissue extract6. Infected cells 
were incubated at 37°C in a 5% CO2 atmosphere in Dulbecco's Modified Eagle Medium 
(DMEM). Cell infection was monitored microscopically by observation of OPV-specific 
cytopathic effect (CPE). In order to quantify the OPV DNA in the pathological samples, a 
Real time SYBR Green PCR was performed
j,o
. The absolute quantification of the viral DNA 
has been obtained by plotting 10-fold dilutions (1.7x101 to 1.7x105 copies/µL) of pUC19 
plasmid containing the cloned target fragment. No CPE was observed in inoculated cell 
culture while the quantitative PCR revealed an OPV load ranging from 10
1
 to 10
3
 DNA 
copies/µL, suggesting that DNA positive samples might not contain viable virus. In 
conclusion, we investigated the aetiological agents responsible for severe cutaneous cases of 
diseases in domestic ruminants using classical diagnostic techniques and an innovative 
molecular probe-based method able to simultaneously identify different zoonotic poxviruses 
within the same sample. Our data lead us to demonstrate that classical techniques, such as 
histopathology and electron microscopy, may not be sufficiently effective and reliable for the 
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diagnosis. The mini-array assay used in this study revealed that some of the animals affected 
by severe proliferative lesions, clinically defined as "papillomas", were in fact co-infected 
with zoonotic PCPV, BPSV and OPV. It is important to emphasize that zoonotic poxviruses 
share risk factors and clinical features with other life-threatening diseases in humans18, for 
this reason, rapid and reliable diagnostic methods, like the one used in this study, have the 
potential to allow the rapid assessment of potentially fatal infections in humans. With the aid 
of this new method, it was possible to demonstrate that two goats and two cows, from 
different farms, were co-infected with different epitheliotropic viruses. In particular, the cattle 
identified as 14647-429 and 33225-498, that showed the presence of papillomavirus particles 
by electron microscopy, were also co-infected with zoonotic poxviruses: BPSV and PCPV 
respectively and a virus belonging to Orthopoxvirus genus. Sant'Ana and colleagues (2013) 
already reported co-infections of Parapoxvirus and Orthopoxvirus in cattle in Brazil9. The 
description of the clinical cases seen in Brazil, were consistent with those found in the Italian 
outbreaks. Despite the large number of diseased animals, the authors were able to demonstrate 
the simultaneous presence of Parapoxvirus and Orthopoxvirus particles, by electron 
microscopy in the pathological sample of only one animal and, as in our study, no CPE was 
detected in inoculated cell cultures. Further trials, using alternative cell substrates, will be 
necessary to rule out the possibly that the pathological samples contained only DNA remnants 
or viral particles with compromised integrity by either the animal immune system or by 
external factors during the sample collection or processing 
11
. These results indicate that tissue 
culture isolation is less sensitive than molecular methods to detect zoonotic poxvirus in co-
infected animals while the mini-array method shows to be reliable, robust and suitable to be 
applied in areas where OPV and PPV co-circulate. 
To our knowledge, this is the first report of OPV infections in domestic ruminants in Italy. 
Co-infections with Orf virus-like parapoxvirus and VACV were already reported in dairy 
cow9 while we identified the simultaneous presence of Orf virus and OPV in two goats. 
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Recently, co-infections with VACV and PCPV in a rural worker and in dairy cow have also 
been described1. This study further proves that co-infections with OPV and PPVs may occur 
in cattle not only involving PCPV but also BPSV. The high sequence identity and the 
circulation of CPXV in Italy in different animal species 
5,6,7 
lead us to conclude that the OPV 
DNA, detected in domestic ruminants might be CPXV. This virus used to be enzootic in 
cattle, however such infections were not diagnosed over the last decades, while individual 
cases of cowpox have been repeatedly found in cats or exotic zoo animals that were 
responsible for human transmission
8,13,16,17,24,26
. It is not possible to conclude that CPXV was 
the causal agent of the lesions reported in domestic ruminants, in fact its low genomic load 
can be the result of the interference caused by multiple viral agents replicating at the same 
time in the same target cell. On the other hand, the presence of CPXV DNA, in the 
pathological samples of domestic ruminants, lead us to speculate that the virus may use these 
animal species as reservoirs to spread and persist in the environment through the scab material 
produced by other epitheliotropic viruses. 
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Figure 1. a) Multiple tumour-like lesions in a goat kid (9605-425) simultaneously infected with zoonotic 
poxviruses; b) hyperkeratosis, hyperplasia, acanthosis and ballooning degeneration of the epidermis 
(Hematoxylin-eosin. Obj. 50×); c) vascular proliferation and hypertrophic endothelia in the superficial dermis 
(Hematoxylin-eosin. Obj. 100×). 
 
 
Figure 2. Mini-array results allowing the simultaneous detection of orthopoxviruses and parapoxviruses. 
  
a 
b 
c 
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Table 1: Epiteliothropic viruses detected in thepathological lesions of diseased animals. The sequences of 
Orthopox detected in cows and goats were submitted to GENBANK and their accession numbers are indicated. * 
DPV = Deltapapillomavirus; XPV = Xipapillomavirus; EPV = Epsilonpapillomavirus; BPSV = Bovine papular 
stomatitis virus; PCPV = Pseudocowpox virus; ORFV = Orf virus; – = negative result. 
 
Source/Animal ID Papillomavirus  Parapoxvirus Orthopoxvirus 
Bovine    
25084-161 δ – – 
31585-156 δ- ξ – – 
75176-153 δ – – 
85704-162 δ – – 
10549-174 ξ – – 
28580-287 δ- ξ BPSV – 
6231-416 δ- ξ- ε PCPV – 
14647-429 δ- ξ BPSV KM881110 
33225-498 δ- ξ PCPV KM881111 
50627-534 δ- ξ BPSV – 
1818 ξ PCPV – 
12748-610 δ PCPV – 
Sheep    
70452-158 – ORFV – 
70461-157 – ORFV – 
73824-159 – ORFV – 
73830-160 – ORFV – 
13173-164 – ORFV – 
13175-305 – ORFV – 
13176-306 – ORFV – 
79157-387 – ORFV – 
Goat    
54836-349 – ORFV – 
9605-425 – ORFV KM881108 
32063-501 – ORFV KM881109 
60945-544 – ORFV – 
 
 
 
Figure 3: Phylogenetic tree generated from alignment 
of complete orthopoxvirus (OPV) Rpo 18 gene 
sequence using the neighbour-joining method and the 
Tamura 3-parameter model of nucleotide substitution, 
implemented in Mega 6. The percentage of replicate 
trees in which the associated taxa clustered together in 
the bootstrap test (1000 replicates) are shown above 
the branches (cutoff 60%). Dots indicate the strains 
object of the study. 
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Abstract  
We identified a novel papillomavirus (CePV1) in a fibropapilloma of a 1,5 year old male red 
deer (Cervus elaphus) shot in the Italian Alps in Brescia province. PV particles were first 
observed by electron microscopy and PV DNA was then identified by PCR using degenerate 
primers. Subsequently we cloned the entire genome and determined its complete sequence. 
CePV1 genome is 8009 bp long and contains all 9 ORFs and the long untranslated regulatory 
region characteristic for Delta-papillomaviruses. Pairwise nucleotide alignments and 
phylogenetic analyses based on concatenated E1-E2-L1 ORFs allowed to determine the 
highest similarity with the Capreolus caprelus papillomavirus CcaPV1. The analysis of the 
host-parasite phylogenetic tree interactions suggest the co-divergence of CePV1 and Cervus 
elaphus while the identified topological incongruences leading us to speculate that CcaPV1 
could eventually be the result of an earlier host switch event.  
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Introduction  
Papillomaviruses (PVs) are small, non-enveloped, double stranded DNA viruses with circular 
genome that ranges between 6800 and 8400 bp. Eight to ten open reading frames (ORFs) are 
encoded, and transcribed from the same DNA strand with the same orientation. Translated 
proteins are classified as early (E) and late (L), based on their temporal expression 
(Gottschling, 2007). According to Bernard and co-workers (2010), the family 
Papillomaviridae contains 29 genera formed by 189 papillomavirus (PV) types isolated from 
humans (120 types), non-human mammals, birds and reptiles (64, 3 and 2 types, respectively) 
designated by Greek letters and classified based on genomic DNA homologies, especially of 
the late L1 structural protein (De Villiers et al., 2004; Bernard et al., 2010). The current 
classification of papillomaviruses is based on the comparison of complete L1 ORF nucleotide 
sequences, distinct Papillomavirus genera sharing less than 60% L1 ORF nucleotide sequence 
identity, while papillomavirus “species” within a genus approximately 60-70% (Bernard et 
al., 2010). Since 2010 the number of animal papillomaviruses has been gradually increasing, 
and new types have been detected, especially in mammals (Alberti et al., 2010; Hatama et al., 
2011; Wood et al., 2011). Papillomaviruses constitute a diverse epitheliotropic group of 
viruses infecting the stratified squamous epithelia of skin and mucosa, and have been 
associated with warts and different types of cancer. PV genomes have been detected in 
papillomas of wild cervid species in Europe and North America (Shope et al., 1958; Lancaster 
and Sundberg, 1982; Moreno-Lopez et al., 1981; McDiarmid, 1975; Moar and Jarrett, 1985; 
Erdélyi et al., 2008; 2009a). The genomes of several cervid papillomaviruses have been 
already sequenced, such as the Deer (White-tailed deer - Odocoileus virginianus) 
Papillomavirus (Groff and Lancaster 1985), the Reindeer (Rangifer tarandus) Papillomavirus 
(Moreno-Lopéz et al., 1981), the European Elk (Alces alces) Papillomavirus (Stenlund et al., 
1983) and the Western roe deer (Capreolus capreolus) papillomavirus (Erdélyi et al., 2008). 
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The majority of cervid papillomaviruses belong to the Delta genus, which includes also 4 
Bovine papillomavirus 1 and 2 (BPV1 and BPV2) and Ovine papillomavirus 1 and 2 (OaPV1 
and OaPV2) (Bernard et al., 2010). A common feature of these viruses is that they induce the 
development of skin tumours with a marked connective tissue component. Our study 
describes the complete genomic sequence of a papillomavirus identified in a cutaneous lesion 
of a 1,5 year old male red deer shot in the Italian Alps in Brescia province. This novel virus 
was named CePV1 following the nomenclature guidelines (Sundberg et al., 1996) for non-
human 76 papillomaviruses.  
Materials and methods Samples During an investigation on parapoxviruses causing diseases 
in wild ruminants of the central Italian Alps in Sondrio and Brescia provinces, the presence of 
a firm cutaneous tumour around 5.5 cm in size with a rough hairless pigmented surface was 
detected on the hind leg during post mortem inspection of a hunted 1,5 year old male red deer 
(Fig. 1). Tissue samples were excised from the tumour for diagnostic purposes and a first set 
of tissue samples was submitted to Istituto Zooprofilattico della Lombardia e dell’Emilia 
Romagna (Brescia, Italy) for identification of the causative agent of the disease by negative 
staining (2,5% NaPT) transmission electron microscopy (TEM). In addition, 5-10 mm3 
portions of the tumour were fixed in 10% neutral buffered formalin and embedded in paraffin. 
Sections were cut at 4μm and stained with haematoxillin eosin (HE) in order to characterise 
the lesion histologically. A further set of tissue samples was kept at -80°C for nucleic acid 
extraction.  
Nucleic acid extraction and PCR DNA was extracted from 25 mg of tumour using 
NucleoSpin Tissue kit (Macherey and Nagel, Düren, Germany) following the manufacturer’s 
instructions. Initially, a PCR reaction was performed to identify a fragment of approximately 
480 bp of L1 gene of papillomaviruses using 5 primers FAP59/FAP64 as described by 
Forslund et al., 1999. Additionally, a PCR reaction using specific primers designed for 
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amplification of a 499 (BPV-1) or 497 bp (BPV-2) fragment spanning the E5 open reading 
frame (ORF) was carried out as described by Brandt et al., 2008. PCR products were purified 
using High pure PCR product kit (Roche, Milano, Italy) according to the manufacturer’s 
instructions and sequenced directly in both directions with the corresponding primers.  
Multiply primed rolling circle amplification Rolling Circle Amplification (RCA) combined 
with restriction enzyme analyses were carried out using the Templiphi amplification kit (GE 
Healthcare, Milano, Italy) following the protocols previously described by Rector et al., 2004 
and Van Doorslaer et al., 2006, in order to identify papillomavirus genomes. Briefly, 5 μl of 
DNA extracted from the neoplastic tissue were mixed with 10 μl of sample buffer and 
subsequently heated for 3 minutes at 95°C, then transferred in an ice-bucket. Ten microliters 
of TempliPhi reaction buffer, 0.4 μ l of TempliPhi enzyme mix containing phi 29 DNA 
polymerase and random hexamers in 50% glycerol and 0,4 μl of 10mM dNTPs per sample 
were mixed and added to the cooled sample and the reaction was subsequently incubated for 
16 hours at 30°C. The phi 29 polymerase was then inactivated at 65°C for 10 minutes. A 
digestion with restriction enzymes EcoRI, BamHI and SacI was subsequently performed and 
the products were run on a 0.8% agarose gel to visualise the presence of a DNA band 
consistent with the length of a papillomaviral genome or multiple bands with sizes adding up 
to this length.  
DNA cloning and sequence analyses  The 8000 bp DNA fragment obtained after the 
digestion of the RCA product with BamHI was cloned into pUC19 vector (Life Technologies, 
Monza, Italy) to generate pUC19/CePV1 IT1127. Briefly, 10 μl of the RCA product was 
digested with 100 units of BamHI for 3 hours and run on a 0.8% agarose gel, after which the 
fragment was extracted using the QIAquick Gel Extraction Kit (Qiagen, Jesi, Italy). The 
fragment was then ligated into the pUC19 vector that was previously cut  with BamHI and 
dephosphorylated, using the Rapid DNA Dephos & Ligation Kit (Roche). The ligation 
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product was used to transform One Shot MAX Efficiency DH5Alpha™-T1R competent cells 
(Life Technologies). Bacteria were incubated for blue-white colony screening on agar plates 
containing X-gal, and white colonies were checked by BamHI digestion of miniprep DNA. 
One clone containing the 8 kb DNA fragment was selected. The complete genome of the 
Cervus elaphus papillomavirus (CePV1) was determined by primer-walking sequencing of 
the cloned DNA fragment (supplementary table S2, Supplementary Material), starting from 
the universal primer sites in the multiple cloning site of pUC19. In addition, in order to avoid 
any carry-over of possible point mutations generated during the amplification procedure, the 
original RCA amplicon was subjected to primer walking and sequencing using the same set of 
primers. Sequencing was performed on an ABI Prism 3100 Genetic Analyzer (Perkin-Elmer 
Applied Biosystems, Foster City, CA, USA). Electropherograms were inspected and edited 
with 4Peaks 1.7.1, and contigs were prepared using SeqMan II (DNASTAR, Madison, WI, 
USA). Prediction of open reading frames (ORFs) was performed using the ORF Finder tool 
on the NCBI server of the National Institutes of Health 
(http://www.ncbi.nlm.nih.gov/gorf.html). Transcription factor binding sites and motifs were 
searched either manually or online using ScanProsite (http://www.expasy.ch/prosite). The 
molecular weight of the putative proteins was calculated using the ExPASy (Expert Protein 
Analysis System) Compute pI/Mw tool (http://www.expasy.org/tools/pi_tool.html). Pairwise 
sequence alignments and sequences similarities were calculated using the ClustalW 
(Thompson et al., 1994).  
Phylogenetic analyses Nucleotide sequence alignments of the CePV1 ORFs with 89 other 
PVs were produced using ClustalW in DAMBE software version 5.0.29 (Xia and Xie, 2001). 
The nucleotide sequences were 7 first translated and aligned at the amino acid level to which 
alignment we fitted the original nucleotide sequences thus obtaining the final nucleotide 
sequence alignment (Larkin et al., 2007). Alternative alignments were also generated by 
omitting the third codon positions. This was done separately for the different ORFs, and the 
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unambiguously alignable parts of the E1, E2, L2, and L1 ORFs were pasted together in one 
compiled alignment. Genetic distances among the operational taxonomic units (OTUs) were 
computed as percent of total nucleotide differences or by the Kimura 2-parameters method 
using MEGA version 2.1 (Kumar et al., 2001), and were used to construct neighbour-joining 
(NJ) trees (Saitou and Nei, 1987). Statistical support for internal branches of the trees was 
evaluated by bootstrapping (Felsenstein, 1985). Maximum parsimony (MP) and Maximum 
likelihood (ML) trees were generated using the same software. Trees were edited using NJplot 
(Perriere and Gouy, 1996) and Treeview v. 1.5.2 (Page, 1996). Co-phylogenetic association of 
Delta-papillomaviruses and their hosts was assessed using the  TreeMap program 
(http://taxonomy.zoology.gla.ac.uk/rod/treemap.html) which explores how the parasite tree 
fits onto the host tree by mixing four types of events: co-divergence, host switching, 
duplication or intra-host divergence of the parasite and sorting or extinction of the parasite 
lineage (Gottschling et al., 2011). With this aim we built the phylogenetic trees of viruses and 
their hosts generated using the distance matrix implemented in the software PAUP* version 
4.0b10. The Delta papillomavirus tree was based on the concatenated alignment of E1, E2, L1 
ORFs (supplementary table S1, Supplementary Material) while the host tree was generated 
after the alignment of the complete mitochondrial genomes (supplementary table S3, 
Supplementary Material).  
Results Viral particles, identified by morphologic features as PV, were observed by negative 
stain electron microscopy in the material collected for pathologic examination from red deer 
IT 1127. Cross sections of the tumour mass were shiny and firm and histological examination 
classified the tumour as a fibropapilloma, showing hyperkeratosis and acanthosis of the 
epidermis, proliferation of fibroblasts and connective tissue. PCR reaction performed with 
FAP59 and FAP64 on DNA extracted from tissue sample IT 1127 confirmed the presence of 
PV DNA. Sequencing of the partial L1 PCR product obtained with FAP primers and 
corresponding to a portion of the L1 region allowed to establish the presence of a CcaPV1 
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variant, according to the criteria of De Villiers et al. (2004), with nucleotide and amino acid 
sequence identity of 91% and 96%, respectively. This new papillomavirus variant was 
designated CePV1. PCR performed with E5 primers detected the simultaneous presence of 
BPV DNA and direct sequencing of the amplified product demonstrated a co-infection with 
BPV-1. The full genome of CePV1 was obtained from sample IT 1127 by RCA that 
successfully generated linear double stranded tandem repeated copies of the circular DNA 
template. The digestion of the obtained double stranded DNA with a panel of restriction 
enzymes generated a pattern consistent with papillomavirus DNA: in particular BamHI, 
EcoRI and Sac I produced a single fragment of about 8 Kb. The 8 kb BamHI fragment was 
successfully cloned into pUC19 vector and the complete genome sequence was obtained by 
primer walking performed on the cloned DNA. The accuracy of the result was subsequently 
confirmed by direct sequencing of the original RCA amplicon. The nucleotide sequence of 
CePV1 full genome was deposited in GenBank using the National Centre for Biotechnology 
Information (NCBI, Bethesda, MD) BankIt v3.0 submission tool 
(http://www3.ncbi.nlm.nih.gov/BankIt/) under accession number JQ744282. All nine Delta 
papillomavirus ORFs have been detected in the CePV1 genome and after nucleotide and 
amino-acid alignments it was possible to define its similarity with other Delta 
papillomaviruses (Table 1). Overall, the highest nucleotide (nt) and amino acid (aa) identity 
was found with CcaPV1 and with reference to the single ORFs the highest similarity was 
found in E4 with 99.1% and 98.2% identity at nt and aa levels, respectively, while the lowest 
similarity was detected in E9 with 89.7% identity at both nucleotide and amino acid level. 
Similarly to CcaPV1, the GC content in the CePV1 genome is approximately 47%, while its 
length was found to be 8009 bp compared to the 8032 bp of CcaPV1. This different length is 
due to the deletion of 14 nucleotides in the untranslated LCR 200 region and of 9 nucleotides 
in L2 gene causing the lack of 3 amino acids (Ser, Ala, Arg) at positions 201 427, 428 and 
479 of the encoded protein. The molecular masses of the putative proteins showed to 202 be 
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similar to those of CcaPV1. The predicted amino acid and nucleotide features are summarized 
in 203 table 2, the main differences found between CePV1 and CcaPV1 consisted in an 
additional E2 204 binding site (ACC-N5-7-GGT) and a further polyadenilation sites 
(AATAAA) detected in the CePV1 genome, respectively at positions 4424-4436 in L2 ORF 
and 1251-1256 in E1 ORF. Furthermore, TATA boxes have been identified in LCR and at 
nucleotide 60 (TATAAA) of E6 ORF as it was found in CcaPV1 and OaPV3 genomes and an 
additional box located in E1 ORF starting at position 1530. The E1 binding site (A 
(A/T)GATTGTTGTTAACAAT) shows a T at position two as it has been found in reindeer 
PV and OaPV2 while CcaPV1 has an A as in BPV-5. Finally, two additional Nuclear factor 1 
(NF1) binding sites (CGGAA) have been identified at positions 490 in E6 ORF and 5658 in 
L2 ORF compared to CcaPV1 and an additional AP-1 (Activator Protein-1) binding sites 
(TGANTCA) was detected at nt 1682 (ORF E1). The pRB-binding domain (L-X-C-X-E) was 
absent in the putative E7 protein as in all Delta-papillomaviruses (Narechania et al., 2004) and 
the putative E4 protein showed the typical high proline content 215 (12.3%). Phylogenetic 
trees were obtained from a concatenated E1/E2/L1 nucleotide sequence alignment of CePV1 
and 89 PV-types representative of the different PV genera and species (Figure 2). Nucleotide 
sequence alignments, based on the corresponding amino acid alignments, were constructed 
separately for the different ORFs. Regions where an unambiguous alignment could be 
obtained were included in one combined alignment of 2814 nucleotides (supplementary Table 
S1, Supplementary Material). The resulting neighbour-joining and maximum likelihood 
phylogenetic trees clustered the PVs in their respective genera, according to the new 
classification of PV (Bernard et al., 2010). In the trees, CePV1 appears as a novel Delta 
papillomavirus, closely related to CcaPV1 (Capreolus capreolus papillomavirus type 1), and 
therefore a representative of the 10 Delta-5 species (Bernard et al., 2010). Maximum 
parsimony and Maximum Likelyhood trees constructed using the same nucleotide alignment 
were in agreement with neighbour-joining trees (data not shown). The comparison of host and 
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virus phylogenetic trees in TreeMap (Figure 3a) resulted in a tanglegram showing several 
topological incongruences while reconstruction (Figure 3b) identified two duplication events 
at the base of the host - virus tree, three co-speciation events and evidence of host switch 
events that shaped PV diversification in deer hosts.  
Discussion 
Papillomaviruses have been already identified in skin tumours of European elk, reindeer, roe 
deer, red deer and North American deer species (e.g. White-tailed deer). A common feature of 
these viruses is that they induce the development of fibropapillomas, skin tumours with a 
marked connective tissue component where fibroblasts appear to be the primary target cells of 
the virus. This is the first reported case of Papillomavirus infection in red deer in Italy, a 
disease that has been sporadically reported in other European Countries such as Spain, France, 
England, Austria and Hungary (Erdélyi et al., 2009a). The age of the affected animal and the 
pathological lesions were similar to those previously reported (Moar and Jarret 1985; Erdélyi 
2009a) with no evidence of tumour metastasis. Our results identified a papillomavirus co-
infection, as nucleid acid amplification evidenced the presence of both BPV-1 and CePV1 
DNA. Nevertheless, quantitative PCR analysis indicated that CePV1 DNA yield was four 
logarithms higher than BPV-1 DNA (data not shown) and confirmed that the clinical lesions 
were ascribable to a productive CePV1 infection. The co-infection of a red deer with BPV-1 
is not surprising, according to the already observed cross species transmission ability of this 
Delta papillomavirus (Nasir and Campo, 2008). The genetic organization of the CePV1 
exhibits a typical Delta papillomavirus architecture with homologous genetic structures 
containing 9 ORFs encoding the regulatory early proteins and late structural proteins as well 
as the non-coding regulatory region (LCR). Phylogenetic analyses 11 allowed us to confirm 
that the red deer PV clusters within the Delta papillomavirus group and represent an 
additional PV variant closely related to CcaPV-1. Papillomaviruses are highly host specific, 
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and it has been generally assumed that these pathogens co-diverged with their mammal hosts 
so that related PVs infect related hosts. Delta papillomaviruses infecting ruminants are often 
quoted as an example for this statement; known as 256 Clay's rule but the absence of 
congruence between virus and host phylogenies has been suggested recently (Bravo et al. 
2010; Gottshling et al., 2011; Mengual-Chuliá et al. 2012). In this study we also identified 
several topological incongruences between the phylogenetic trees of the mammal hosts and 
their viruses, and we suggest that CePV1 could have evolved during co-speciacion with its 
host Cervus elaphus. CePV1 is the closest relative of CcaPV1, identified in roe deer 
(Capreolus capreolus). According to Gilbert et al (2006) red deer and roe deer belong to 2 
different subfamilies within the Cervidae family: the Cervinae and the Capreolinae and thus 
to the clades of Plesiometacarpalia and Telemetacarpalia. A similar incongruence was already 
reported for AaPV1 isolated from European elk (Alces alces) that showed to be the closest 
relative of reindeer PV (RPV) isolated from Rangifer tarandus, and not of OvPV1 isolated 
from Odocoileus virginianus as it would have been expected if host phylogenesis was 
congruent (Gottschling et al., 2011). Co-divergence plays an important evolutionary role in 
PVs and our data lead us to speculate that CePV1 can be the result of a co-speciation between 
the virus and its host. Co-speciation is not the only event that shaped PV diversification 
(Gottshling et al. 2011) in fact other events such as duplication and host switching can disrupt 
the topological congruence between the phylogenetic trees of Delta papillomaviruses and their 
hosts. The high similarity found between CePV1 and CcaPV1, seems to indicate that these 
PVs belong to the same ancestral lineage and our data provide evidence that CcaPV1 can be 
the result of a host switch event. Interspecies transmission of viruses is a broadly accepted 
phenomenon but it is still debated whether it requires adaptation to a new host during the 
early stages of infection or whether transmission itself could be a largely random process 
(Dennehy et al., 2006). The primary transmission route of cutaneous papillomaviruses is 
through 12 direct contact with contaminated environment or infected animals shedding the 
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virus from the surface of tumours. In European countries, where red deer fibropapillomas 
have been reported, there is no evidence of a similar infection in roe deer. At present Hungary 
is the only European country in which there is a coexistence of CePV1 and CcaPV1 infection 
in local deer population. Erdélyi and collaborators (2009b) speculated that the endemic nature 
of roe deer fibropapillomatosis in Hungary could be linked to the genetic differentiation 
pattern of European roe deer populations. An alternative explanation could be linked to 
peculiarities of deer habitat use and geography. The habitat use of deer has been widely 
studied in the European countries where the diseases has been detected (Birò et al., 2006; San 
José et al., 1997; Prokesòva et al., 2006), leading to demonstrate that inter-specific spatial 
interference between red and roe deer may vary on a wide scale also providing opportunities 
for virus transmission from one species to the other. Although habitat change due to 
agriculture and modern land use practices greatly modify the ecology of modern deer, with a 
potential to intensify inter-specific spatial interference, we must not forget that the current PV 
phylogeny reflects much older evolutionary processes. The mechanism of inter species 
transmission gaining a new hosts for CePV1 should be studied further in the light of the fact 
that other Delta papillomaviruses such as BPV-1 and 2 have already shown to be 
transmissible even to phylogenetically distant animal species. In conclusion, our results are 
consistent with the findings of Bravo and co-workers (2010), suggesting that the current PV 
classification system should be revised and an alternative naming approach should be 
considered, since host specificity is not always strictly maintained in animal papillomaviruses. 
Consequently, it is not correct to assume that the host species in which a PV was first detected 
is the original host. More sequence data from a larger number of deer viruses and extensive 
epidemiological studies will be required to better understand the evolution of deer 301 
papillomaviruses and their hosts.  
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Figure 1: Nodular hairless mass covered with dark and dry skin localised on the inner surface of a hind leg. 
 
 
 
 
Figure 2: Coinciding NJ and ML trees based on a 2814 bp concatenated E1/E2/L1 nucleotide sequence 
alignment of CePV1 and other animal and human PV types. The numbers at the internal nodes represent the 
bootstrap support values, determined for 10,000 iterations with the neighbour-joining method. 
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Figure 3: a) –upper-Congruence between Delta-papillomaviruses (right) and mammal host species (left). The 
Tanglegram built with TreeMap links the phylograms of PVs with their hosts, central linking lines represent 
specific virus-host associations. 3 b)-lower- Reconstruction showing co-divergence (black squares), duplication 
(black dots) and host switch events (black arrows). 
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Table 1: Nucleotide and amino acid identity among Delta-papillomaviruses. 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Nucleotide and amino acid features of CePV genome. Underlined positions represent characteristic 
motifs which are not present in CcaPV1. 
Predicted nt features CcaPV1 
GenBank n. EF680235 
CcePV1 (IT-1127) 
GenBank n. JQ744282 
genome size (bp) 8032 8009  
GC content (%) 47,31 47 
E2 binding site 
(ACC-N5-7-GGT) 
73 (LCR); 231 (E6); 3770 (E2); 4552 (L2); 
7476 (LCR); 7610 (LCR); 7661 (LCR): 7711 
(LCR); 7794 (LCR); 7818 (LCR); 7858 
(LCR); 7982 (LCR) 
 
103 (E6); 3642 (E2); 4424 (L2); 4905 
(L2); 7336 (LCR); 7470 (LCR); 7521 
(LCR); 7571 (LCR); 7654 (LCR); 7678 
(LCR); 7707(LCR); 7831 (LCR); 7954 
(LCR) 
E1 binding site 
(A(A/T)GATTGTTGTTAACAAT) 
AAGATTGTTGTTAACAAT ATGATTGTTGTTAACAAT 
Poly adenilation sites (AATAAA) 4351 (E9); 6399 (L1); 7704(LCR); 
7429(LCR);  
4223(E9); 6262(L1); 7292(L1); 
7564(LCR); 1251(E1) 
Tata box 
(TATAAA or TATA(A/T)A(A/T) 
60 (LCR)  1530 (E1); 7941(LCR) 
SP1 binding sites (GGCGGG) 1001 (E1) 872 (E1) 
NF1 binding sites (CGGAA) 3542(E2); 3339(E2/4); 5081(L2); 490(E6); 3211(E2/4); 3414 (E2); 4397 
(L2) ;4871(L2); 5658 (L2) 
AP1 binding site (TGANTCA) 532 (E6/7) 403(E6/7); 1682 (E1) 
Predicted aa-feature 
ATP-dependent helicase motifs in E1 
(GPPNTGKS) 
439-446 aa 413-563 aa 
zinc-binding motifs in E6 (CX2CX29CX2C) 11-47 aa; 83-119 aa  11-47 aa; 83-119 aa 
zinc-binding motifs in E7 (CX2CX29CX2C) 65-101 aa 65-101 aa 
Leucine zipper domain in E1 
(LX5-7 LX5-7 LX5-7L) 
259-280 aa 
266-287 aa 
259-280 aa 
266-287 aa 
Leucine zipper domain in E2 
(LX5-7 LX5-7 LX5-7L) 
/ / 
E4 proline content 11,4% 12,3% 
 
 
 
 
CePV1 CcPV1 OvPV RtPV AaPV OaPV2 OaPV1 BPV1 BPV2 
E6 (405) 96(92,6) 54,3(43.7) 56,9(51,9) 58,1(50,4) 50,3(41,1) 50,3(40,3) 56,6 (46,2) 55,6(46,9) 
E7 (327) 96,3(95,4) 55,6(41,2) 41,7(11,9) 58,2(46,6) 54,2 (46) 54,3(44) 56(46,8) 54,1(45) 
E1 (1839) 96,5(96,2) 71,5(69,7) 70,8(68,6) 69,1(66,6) 68,9(65,5) 68,3(64,7) 64,1(59) 63,8(59,6) 
E2 (1224) 97,6(98) 65,3(55,6) 63,5(54,6) 63,4(51,1) 60,4(55,9) 63,2(55) 59,9(49,2) 59,2 (34,6) 
E4 (342) 99,1(98,2) 65,8(54,5) 63(52,3) 61,7(57,7) 71,2 69,1 (58) 57,8(32,7) 55,6(37,6) 
E5 (141) 93,6(91,5) 59,7(37,8) 55,2(44,4) 59,8(43,2) 57,1(46,8) 53,9(46,8) 57,5 (37,8) 57,5 (37,8) 
E9 (174) 89,7(89,7) 52 (31) 49,6 (31,6) 44,3 (34,9) x x 44,9 (17,6) 43,1(19,6) 
L2 (1455) 92,9(93,2) 67,1 (61,1) 64,1(64,2) 67 (66,5) 61,1(54,6) 60,2 (56) 54,5(48,9) 57,2 (50,9) 
L1 (1524) 94,3(97,2) 71,4(77,1) 71,9(80,2) 72,3(79,2) 69,3(74,7) 67,5(72,9) 68,6(75,4) 68,9(74,7) 
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Table S1: Scientific names, host species, lesion/isolation sites, phylogeny, GENBANK accession numbers, and references of the 89 papillomaviruses considered in the 
phylogenetic analyses. Papillomavirus nomenclature and phylogeny are indicated according to the new proposal for taxonomic amendments as in: “Bernard, H. U., R. D. Burk, Z. 
Chen, K. Van Doorsiaer, H, zur Hausen, and E. M. de Villers. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology: 
doi:10.1016/j.virol.2010.02.002”. 
Scientific name Scientific 
abbreviation 
 
Host Lesion/isolation site Phylogeny GenBank 
Accession 
Number 
Reference  
(* direct submission) 
Alces alces papillomavirus 1 AaPV1 Alces alces (Linnaeus, 1758)  
(Cervidae, Artiodactyla) 
Epithelial layer of cutaneous 
warts  
Delta-1 M15953 Ahola et al. (1986) 
Bos taurus Papillomavirus 1 BPV1 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Fibropapilloma of skin  Delta-4 X02346  Chen et al. (1982) 
Bos taurus Papillomavirus 2 BPV2 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Fibropapilloma of skin Delta-4  M20219 Groff and Lancaster (1986)* 
Bos taurus Papillomavirus 3 BPV3 Bos taurus (Linnaeus, 1758) 
(Bovidae, Artiodactyla) 
 
Hyperplasic epithelial warts Xi AF486184  Terai et al. (2002) 
Bos taurus Papillomavirus 4 BPV4 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Esophagus papilloma Xi  X05817  Patel et al. (1987) 
Bos taurus Papillomavirus 5 BPV5 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
‘‘Rice grain’’ papilloma of 
benign 
tumor of teat 
Epsilon  AF457465 Terai et al. (2002) 
Bos taurus Papillomavirus 6 BPV6 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Frond epithelial papillomas of 
udder 
Xi  AJ620208  Jarrett et al. (1984) 
Bos taurus Papillomavirus 7 BPV7 Bos taurus (Linnaeus, 1758)  Teat ? DQ217793 Ogawa et al. (2004) 
92 
(Bovidae, Artiodactyla) 
Bos taurus Papillomavirus 8 BPV8 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Papillomas Epsilon  DQ098913  Tomita et al. (2007) 
Bos taurus Papillomavirus 9 BPV9 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Epithelial squamous papilloma 
lesions on teats 
Xi AB331650 
 
Hatama et al. (2008) 
 
Bos taurus Papillomavirus 10 BPV10 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Epithelial squamous papilloma 
lesions on teats 
Xi  AB331651  
 
Hatama et al. (2008) 
 
Bos taurus Papillomavirus 11 BPV11 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
cutaneous warts Xi AB543507 
 
Hatama et al. (2011) 
 
Bos taurus Papillomavirus 12 BPV12 Bos taurus (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Epithelial papilloma located on 
the tongue of an infected cow 
Xi JF834523 
 
Zhu et al. (2012) 
Canis familiaris oral Papillomavirus CPV1 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Papilloma of 5-month-old  
female beagle 
Lambda-2 D55633 Isegawa et al. (1994) 
Canis familiaris Papillomavirus 2 CPV2 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Foot pad papilloma of a Golden 
retriever 
Tau AY722648 Yuan et al. (2007) 
Canis familiaris Papillomavirus 3 CPV3 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Skin lesions from 7-year-old 
Rhodesian ridgeback with 
canine EV and in situ 
squamous cell carcinoma 
Chi-1 DQ295066 
 
Tobler et al. (2006) 
Canis familiaris Papillomavirus 4 CPV4 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Biopsy specimen of pigmented 
lesions from European pug 
Chi-2 EF584537  
 
Tobler et al. (2008)* 
Canis familiaris Papillomavirus 5 CPV5 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Pigmented plaques Chi-1 FJ492743 
 
Lange et al. (2009a) 
Canis familiaris Papillomavirus 6 CPV6 Canis familiaris (Linnaeus, 1758) Inverted papillomas Lambda-3 FJ492744 Lange et al. (2009a) 
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 (Canidae, Carnivora)  
Canis familiaris Papillomavirus 7 CPV7 Canis familiaris (Linnaeus, 1758) 
 (Canidae, Carnivora) 
Exophytic warts, in situ SCC Tau FJ492742 
 
Lange et al. (2009a) 
Capreolus capreolus Papillomavirus 1 CcaPV1 (Capreolus capreolus, Linnaeus 1758) 
(Odocoileinae, Cervidae, Ungulata) 
Fibropapillomatous skin lesions Delta-5 NC_011051 
 
Erdélyi et al. (2008) 
Capra hircus Papillomavirus 1 ChPV1 Capra hircus (Linnaeus, 1758) 
(Bovidae, Artiodactyla) 
Healthy skin of year-old female Phi DQ091200 Van Doorslaer et al. (2006) 
Caretta caretta Papillomavirus 1 CcPV1 Caretta caretta (Linnaeus, 1758) 
 (Cheloniidae, Testudines) 
Epidermal lesions Dyozeta EU493092 Herbst et al. (2009) 
Chelonia mydas Papillomavirus 1 CmPV1 Chelonia mydas (Linnaeus, 1758) 
(Chelonidae, Testudines) 
Epidermal lesions Dyozeta EU493091 Herbst et al. (2009) 
Colobus guereza papillomavirus 1 
 
CgPV1 Colobus guereza, (Rüppell, 1835) 
(Cercopithecidae, Primates) 
Hand and foot papillomas 
 
Alpha-14 GU014532 
 
Wood et al. (2011) 
 
Equus caballus Papillomavirus 1 EcPV1 Equus caballus (Linnaeus, 1758) 
(Equidae, Perissodactyla) 
Cutaneous papilloma Zeta AF498323 Ghim et al. (2004) 
Equus caballus Papillomavirus 2 EcPV2 Equus caballus (Linnaeus, 1758) 
(Equidae, Perissodactyla) 
Genital neoplasia Dyoiota Eu503122 Scase et al.  (2010) 
Erethizon dorsatum Papillomavirus 1 EdPV1 Erethizon dorsatum 
(Linnaeus, 1758) 
(Erethizontidae, Rodentia) 
Epidermal hyperplasia, with 
acanthosis and orthokeratotic 
hyperkeratosis, from multiple 
white to light brown lobulated, 
raised, firm masses on foot 
pads 
Sigma AY684126 
 
Rector et al. (2005a) 
Erinaceous europaeus Papillomavirus 1 EePV1 Erinaceus europaeus (Linnaeus, 1758) 
(Erinaceidae, Insectivora) 
free-ranging adult male facial 
hair follicles 
Dyoeta  FJ379293  Schulz et al. (2009) 
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Felis domesticus Papillomavirus 1 FdPV1 Felis silvestris (Schreber, 1775) 
(Felidae, Carnivora) 
hyperkeratotic cutaneous 
lesions of a Persian domestic 
cat 
Lambda-1 AF480454 Tachezy et al., (2002a) 
Felis domesticus Papillomavirus 2 FdPV2 Felis silvestris (Schreber,1775) 
(Felidae, Carnivora) 
Bowenoid in situ squamous cell 
carcinoma 
Dyotheta EU796884 Lange et al. (2009b) 
Fringilla coelebs Papillomavirus FcPV1 Fringilla coelebs (Linnaeus, 1758) 
(Fringillidae, Passerida) 
Epithelial warts on tarsus and 
feet 
Eta  AY057109  Terai et al. (2002) 
Francolinus leucoscepus Papillomavirus 1 FlPV1 Francolinus leucoscepus (Grey, 1867) 
(Phasianidae, Galliformes) 
Healthy skin Dyoepsilon Eu188799 Van Doorslaer et al. (2009) 
Human Papillomavirus 1, HPV1 HPV1 Homo sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Plantar wart Mu-1 NC_001356 
 
Danos et al. (1982) 
Human Papillomavirus 101, HPV101 HPV101 H. sapiens(Linnaeus, 1758)  
(Hominidae, Primates) 
Cervicovaginal cells from a 
34-year-old woman with 
intraepithelial neoplasia 
grade 3 
Gamma-6 DQ080081 Chen et al. (2007) 
Human Papillomavirus 103, HPV103** HPV103 H. sapiens(Linnaeus, 1758)  
(Hominidae, Primates) 
Cervicovaginal cells from 30-
year-old woman with normal 
cytology 
Gamma-6 DQ080078 Chen et al. (2007) 
Human Papillomavirus 16, HPV16 HPV16 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Invasive cervical carcinoma Alpha-9 K02718 Seedorf et al. (1985) 
Human Papillomavirus 17, HPV17** HPV17 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Not specified Beta X74469 Delius and Hoffman (1994) 
Human Papillomavirus 18, HPV18 HPV18 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Cervical cancer  Alpha-7 X05015 Cole and Danos (1987) 
Human Papillomavirus 2, HPV2 HPV2 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Pooled DNA from warts of 
different patients 
Alpha-4  X55964 Hirsch-Behnam et al. (1990) 
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Human Papillomavirus 21, HPV21** HPV21 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Skin warts of an 
epidermodysplasia 
verruciformis (EV) patient 
Beta U31779 Kremsdorf et al. (1984) 
 
Human Papillomavirus 25, HPV25** HPV25 H. sapiens(Linnaeus, 1758)  
(Hominidae, Primates) 
Not specified Beta X74471 Delius and Hoffman (1994) 
Human Papillomavirus 38, HPV38** HPV38 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Superficial spreading malignant 
melanoma of an 
immunosuppressed patient 
Beta U31787 Scheurlen et al. (1986) 
Human Papillomavirus 4, HPV4 HPV4 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Wart from EV patient Not 
specified  
Gamma-1 X70827 Egawa et al. (1993) 
Human Papillomavirus 41, HPV41 HPV41 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Disseminated facial, perianal, 
and foot warts from 15-year-
old girl, skin carcinomas, and 
premalignant keratoses 
Nu-1 X56147 Hirt et al. (1991) 
Human Papillomavirus 48, HPV48 HPV48 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Squamous cell carcinoma of 
the hand of immunosuppressed 
36-year-old woman 
Gamma-2  U31789 Muller et al. (1989) 
Human Papillomavirus 49, HPV49 HPV49 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Pooled flat warts Beta-3 X74480 Delius and Hofmann (1994) 
Human Papillomavirus 5, HPV5 HPV5 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Flat wart from EV patient Beta-1 M17463 Zachow et al. (1987) 
Human Papillomavirus 50, HPV50 HPV50 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Actinic keratosis from EV 
patient  
Gamma-3 U31790 Favre et al. (1989) 
Human Papillomavirus 54, HPV54 HPV54 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Penile Buschke-Lo¨wenstein 
tumour coexisting with 
Condylomata acuminata  
Alpha-13 U37488 Farmer (1990)* 
Human Papillomavirus 6, HPV6 HPV6 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Condyloma acuminata Alpha-10 X00203 Schwarz et al. (1983) 
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Human Papillomavirus 60, HPV60 HPV60 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Keratinous plantar cyst  Gamma-4 U31792 Matsukura et al. (1992) 
Human Papillomavirus 63, HPV63 HPV63 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Pooled punctuate keratotic 
lesion 
Mu-2 X70828 Egawa et al. (1993) 
Human Papillomavirus 75, HPV75** HPV75 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Not specified Beta Y15173 Delius et al. (1998) 
Human Papillomavirus 8, HPV8** HPV8 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Not specified Beta M12737 Fuchs et al. (1986) 
Human Papillomavirus 9, HPV9 HPV9 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Flat wart from EV patient Beta-2 X74464 Delius and Hofmann (1994) 
Human Papillomavirus 92, HPV92 HPV92 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Basal cell carcinoma of 89-
year-old man 
Beta-4 AF531420 Forslund et al. (2003) 
Human Papillomavirus 93, HPV93** HPV93 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Solar keratosis on dorsum of 
hand of a non-
immunosuppressed male  
Beta AY382778 Vasiljevic et al. (2007) 
 
Human Papillomavirus 96, HPV96** HPV96 H. sapiens (Linnaeus, 1758)  
(Hominidae, Primates) 
Perilesional skin of a squamous 
cell carcinoma in situ,  
Beta AY382779 Vasiljevic et al. (2007) 
Lynx rufus Papillomavirus 1 LrPV1 Lynx rufus (Schreber, 1777) 
(Felidae, Carnivora) 
Tongue lesion Lambda-1 AY904722 Rector et al. (2007) 
Macaca mulata Papillomavirus 1, MmPV1 RhPV1 Macaca mulata (Zimmermann, 1780) 
(Cercopithecidae, Primates) 
Penile squamous cell 
carcinoma  
Alpha-12 M60184 Ostrow et al. (1991) 
Mastomys coucha Papillomavirus 2 McPV2 M. coucha (Smith, 1834) 
(Muridae, Rodentia) 
Anal lesion  Pi-1 DQ664501  Nafz et al. (2008) 
Mastomys natalensis Papillomavirus 1 MnPV1 Mastomys natalensis (Smith, 1834)  Benign and malignant 
proliferations of adult animals 
Iota  U01834  Tan et al. (1994) 
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 (Muridae, Rodentia) 
Mesocricetus auratus Papillomavirus 1 MaPV1 Mesocricetus auratus (Waterhouse, 1839) 
(Muridae, Rodentia) 
Lesions in lingual mucosa  Pi-2 E15111  Iwasaki et al. (1997) 
Odocoileus virginianus Papillomavirus 1 OvPV1 Odocoileus virginianus (Zimmermann, 
1780)  
(Cervidae, Artiodactyla) 
Pooled fibromas of females Delta-2 M11910 Groff and Lancaster (1985) 
Oryctolagus cuniculus Papillomavirus 1 OcPV1 Oryctolagus cuniculus (Linnaeus, 1758) 
(Leporidae, Lagomorpha) 
Pooled from lesions at 
underside of tongue 
Kappa-1  AF227240 Christensen et al. (2000) 
Ovis aries Papillomavirus 1 OaPV1 Ovis aries (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Fibropapilloma Delta-3  U83594 Karlis et al. (2000)* 
Ovis aries Papillomavirus 2 OaPV2 Ovis aries (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Fibropapilloma Delta-3 U83595 Karlis et al. (2000)* 
Ovis aries Papillomavirus 3 OaPV3 Ovis aries (Linnaeus, 1758)  
(Bovidae, Artiodactyla) 
Squamous cell carcinoma Dyokappa  Alberti et al. (2010) 
Pan paniscus Papillomavirus 1 PpPV1  Pan paniscus (Schwartz, 1929)  
(Hominidae, Primates) 
Focal epithelial hyperplasia-
like disease in oral cavity 
Alpha-10 X62844 Van Ranst et al. (1991) 
Pan troglodytes papillomavirus 1, PtPV1** PtPV1 Pan troglodytes (Blumenbach, 1775) 
(Hominidae, Primates) 
Focal epithelial hyperplasia-
like disease 
Alpha-10 AF020905 Scinicariello F, Soza I, Brasky 
KM and Hilliard JK (1997)* 
Procyon lotor Papillomavirus 1 PlPV1 Procyon lotor (Linnaeus, 1758) 
(Procyonidae, Carnivora) 
Papillomatous skin lesions of 
an adult raccoon 
Lambda-4 AY763115  Rector et al. (2005b) 
Puma concolor papillomavirus 1 PcPV1 Puma concolor (Linnaeus 1771) 
(Felidae, Carnivora) 
Papillomatous lesion under the 
tongue 
Lambda-1 AY904723 Rector et al. (2007) 
Psittacus erithacus Papillomavirus 1 PePV1 Psittacus erithacus timneh (Fraser, 1844) Cutaneous lesion at head Theta  AF420235  Tachezy et al. (2002b) 
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(Psittacidae, Psittaciformes) 
Panthera leo persica Papillomavirus 1 PlpPV1 Panthera leo persica (Meyer, 1826) 
(Felidae, Carnivora) 
Papilloma lesions of tongue Lambda-1 AY904724 Rector et al. (2007) 
Phocaena spinipinnis Papillomavirus 1 PsPV1 Phocaena spinipinnis (Burmeister, 1865) 
(Phocoenidae, Cetacea) 
Genital slit wart Omikron AJ238373 Van Bressem et al. (2007) 
Rangifer tarandus papillomavirus 1, RtPV1 Rangifer tarandus (Linnaeus, 1758) 
(Cervidae, Artiodactyla) 
Epithelial layer of a cutaneous 
fibropapilloma 
Delta-1 AF443292 Moreno-Lope´z et al. (1987); 
Rousettus egyptiacus Papillomavirus 1 RaPV1 Rousettus egyptiacus (E. Geoffroy, 1810) 
(Pteropodidae, Chiroptera) 
Basosquamous carcinoma on 
the left wing membranes 
Psi  DQ366842 Rector et al. (2006) 
Rattus norvegicus papillomavirus 1 RnPV1 Rattus Norvegicus (Berkenhout, 1769) Oral mucosa Pi-1 Gq180114 Schulz et al. (2009b) 
Sus scrofa Papillomavirus 1 SsPV1 Sus scrofa domestica (Linnaeus, 1758) 
(Muridae, Rodentia) 
Healthy skin of a female 
domestic pig 
Dyodelta EF395818 Stevens et al. (2008a) 
Sylvilagus floridanus Papillomavirus 1, SfPV1 Sylvilagus floridanus (J. A. Allen, 1890) 
(Leporidae, Lagomorpha) 
Pooled papillomas  Kappa-2  K02708 Giri et al., 1985 
Sylvilagus floridanus Papillomavirus 1, SfPV1b** Sylvilagus floridanus (J. A. Allen, 1890) 
(Leporidae, Lagomorpha) 
Pooled papillomas Kappa-2  AJ243287 Salmon et al. (2000) 
Trichechus manatus latirostris 
Papillomavirus 1 
TmPV1 Trichechus manatus latirostris  
(Harlan, 1824) 
 (Trichechidae, Sirenia)  
Sessile papillomatous skin 
lesion of female  
FL, United 
States  
AY609301 Rector et al. (2004) 
Tursiops truncatus Papillomavirus 1, TtPV1 TtPV1 Tursiops truncatus (Montagu, 1821) 
(Delphinidae, Cetacea) 
Genital wart on penis Upsilon-1 EU240894 Rector et al. (2008) 
Tursiops truncatus Papillomavirus 2, TtPV2 TtPV2 Tursiops truncatus (Montagu, 1821) 
(Delphinidae, Cetacea) 
Genital Condylomata  Upsilon-2 AY956402 
 
Rehtanz et al. (2006) 
Tursiops truncatus Papillomavirus 3, TtPV3 TtPV3 Tursiops truncatus (Montagu, 1821) 
(Delphinidae, Cetacea) 
Genital wart on penis Upsilon-1 EU240895 Rector et al. (2008) 
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Uncia Uncia papillomavirus 1 UuPV1 Uncia  uncia (Schreber 1775)  
(Felidae, Carnivora) 
Lesion of the lower lip Lambda-1 Dq180494 Rector et al. (2007) 
Ursus maritimus Papillomavirus 1 UmPV1 Ursus maritimus (Phipps 1784) 
(Ursidae, Carnivora) 
Oral mucosa of a polar bear 
 
Omega EF536349 Stevens et al. (2008b) 
 
 
Table S2: Primers used for the complete sequencing of the CePV1 genome. The attachment position of each primer is based on the GenBank accession JQ744282 
Primer sequence genome position 
E1endF 5’-CCTTGTCCCACCGATGAGAAT-3’ 2340-2360 
E1startR2 5’-GCACCTGAGATTCATCATCAC-3’ 766-786 
L1startR 5’-TATCTGGAAGTGCAAACTGA-3’ 5931-5950 
L1endF 5’-ACAGGCCAGATGCAGGTTCAT-3 6221-6241 
L2endR 5’-CTCTGCTCACACCAATCCTAC-3’ 5164-5184 
L1endFII 5’-TCCTGGAGCACTGGGACAT-3’ 6893-6911 
E2E4startFII 5’-TCACCTTAGACACAACCTTGAAG-3’ 3069-3091 
L2startR 5’-CAGTATCTTATCTGCAACAGT-3’ 4352-4372 
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Table S3: Scientific names, GENBANK accession numbers, and references of the genomic sequences of the 
animal hosts considered in the host-parasite interactions analyses. 
Species Source GENBANK 
accession 
number 
Reference 
Odocoileus virginianus mithocondrial genome 
bases 1-16480 
JN632672 Hassanin,et al., 2012   C. R. Biol. 335 (1), 32-50  
Alces alces mithocondrial genome bases 1-16417 JN632595 Hassanin,et al., 2012   C. R. Biol. 335 (1), 32-50  
Ovis aries mithocondrial genome 
bases 1-16616 
AF010406 Hiendleder  et al., 1998  
Anim. Genet. 29 (2), 116-122 
Capreolus capreolus mithocondrial genome 
bases 1-16358 
JN632610 Hassanin,et al., 2012   C. R. Biol. 335 (1), 32-50  
Bos taurus  mithocondrial genome  bases  1 to 
16338 
AF492351 Hiendleder et al. 2008 Cytogenet. Genome Res. 120 (1-2), 
150-156  
Rangifer tarandus mithocondrial genome bases 1 - 
16362 
AB245426 Wada et al. 2005 
unpublished 
Cervus elaphus mithocondrial genome bases 1-16357 AB245427 Wada et al. 2005 
unpublished 
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Abstract 
An investigation on healthy skin and mucosal specimens of wild ruminants shot in the Italian 
Alps in Belluno province has been performed. We report for first time the presence of BPV-2 
DNA in the healthy skin of wild ruminants and the co-infection of BPV-1 and CePV-1 in a 
healthy red deer. Besides the Delta PVs, already known to infect species different from their 
specific host, a cross-infection of BPVs belonging to Xi-genus, found as single infection and 
also in association with Delta BPV types 1 and 2 has been demonstrated confirming that host 
tropism of PVs is not as species-speciﬁc as previously thought. Our results suggest that 
subclinical infections could be linked to the presence of domestic ruminants sharing the same 
habitat with wild species and that the latter may act as reservoir for domestic species’ PVs.  
Keywords: bovidae, cervidae, co-infection, mucosa, papillomavirus, skin 
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Introduction 
The family Papillomaviridae comprises over 32 genera infecting animals (Rector and Van 
Ranst 2013). In ruminants papillomaviruses (PVs) belonging to genera Delta (BPV-1, 2, 13, 
BgPV-1, CcaPV-1, OaPV-1, 2, OvPV-1, AaPV-1), Epsilon (BPV-5, 8), Xi (BPV3, 4, 6, 9, 10, 
11, 12), Phi (ChPV-1), Dyolambda (OaPV-3, RrupPV-1) and Dyoxi (BPV-7), induce 
hyperplastic benign lesions of both cutaneous and mucosal epithelia that generally regress. 
The disease may occasionally persist with the possibility to evolve into cancer in the presence 
of environmental carcinogenic co-factors. 
Papillomaviruses are known to be highly species specific, with the exception of Bovine 
papillomavirus types 1 and 2 (BPV-1, 2), and more recently BPV-13 (Lunardi et al. 2013). 
These viruses belong to the genus Delta papillomavirus and they are all causative agents of 
equine sarcoid in horses and donkeys (Lancaster et al. 1979; Amtmann 1980; Lunardi et al. 
2013) even if they were also detected in wild species (Löhr et al. 2005; Literák et al. 2006; 
Kidney and Berrocal, 2008; Silvestre et al. 2009; van Dyk et al. 2011). PVs infect the basal 
layer of cutaneous or mucosal epithelial cells of vertebrates; infections occur via microlesions 
of proliferating basal layer cells. Virus spread occurs by virus release from the surface of 
warts and papillomatous lesions which frequently contain large quantities of viral particles 
within their superficial differentiated layers. Following infection, there are two potential 
outcomes: a clinically apparent lesion may form or, the onset of a clinically silent infection. 
The latter may or may not involve the completion of the full productive virus life cycle, where 
new virions are not formed representing a form of viral latency (Maglennon and Doorbar, 
2012) with a possible reactivation under conditions of immunosuppression. The presence of 
the virus is well documented in healthy skin of humans and different other animal species 
(Antonsson and Hansson, 2002; Antonsson and McMillan 2006) as a presumed commensal 
agent (Antonsson et al. 2003). Papillomovavirus infections have been recently reported in a 
red deer (Cervus elaphus) from the Alps of Stelvio Park (Scagliarini et al. 2013) and from a 
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chamois (Rupicapra rupicapra) from Val d'Aosta Alps (Mengual Chulià, 2014). Despite a 
very limited morbidity, these two cases proved the circulation of papillomaviruses among 
Alpine wild ruminants leading to speculate a role of reservoir for these animal species. This 
study was aimed at investigating the distribution of papillomaviruses in Alpine wild 
ruminants, to address this issue, PCR assays with previously published primer combinations 
targeting the L1 open reading frame (ORF) were performed. 
 
Materials and Methods  
A total of 112 samples collected from 32 deer (Cervus elaphus), 13 chamois (Rupicapra 
rupicapra), 5 roe deer (Capreolus capreolus) and 6 mouflons (Ovis musimon) shot within the 
faunal control program were sampled. Skin from coronary band and labial mucosa were 
harvested, and each subject was identified with the same serial number and a letter depending 
on the site of sampling (Z= coronary band; B= labial mucosa). None of the subjects showed 
any lesion referable to epitheliotropic viruses neither on the sampling site nor on the rest of 
the body. After collection, all samples were conserved -80°C until processed. 
DNA was extracted from samples with Nucleo Spin Tissue (Macherey-Nagel). The 
cytochrome C oxidase subunit I (COX I) gene, was amplified (data not shown) and used as 
indicator of nucleic acid extraction and quality of samples. 
PCR reactions were  performed with “Taq PCR Master Mix Kit” (Qiagen) on a final volume 
of 25μl containing 1X PCR buffer, 5 μl of Q-solution, 0,8 mM deoxynucleotide mix (Thermo 
Scientific), 0,4 μM of sense and antisense primer, 2,5 μl of DNA template and 0,65 units of 
Taq DNA polymerase.  The amplification program consisted of an initial denaturation step of 
94°C for 5 min followed by 40 thermal cycles [94°C 30 sec; AT 30 sec; 72°C 1 min] and a 
final elongation step at 72°C for 5 min. 
All samples have been amplified with BPV types 1 and 2 (Delta) and BPV Xi-genus specific 
primer pair (BPV310F/R AT: 52°C), and if found positive for the latter, type specific (BPV-3, 
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6, 9, 10) amplification was performed (BPV3/6F AT: 52°C; BPV9F/R AT: 60°C; BPV10F/R 
AT: 60°C. Mouflons were also tested with Ocp1s/2r primer pair (kindly provided by Alberti 
A. University of Sassari) targeting OaPV-1, 2 and 3 (Ovis aries) as well as ChPV-1 (Capra 
hircus). CePV-1 (Cervus elaphus) primer pair (L1 end F2/E1 start R2 AT 55°C) was used to 
screen all red deer samples (Table 1). Each reaction included a no template control (NTC), an 
appropriate positive control consisting in a previously sequenced PV type. All standard 
precautions adhering to strict laboratory practices were followed to prevent any 
contamination. Different steps (DNA extraction, sample preparation, amplification) were 
performed in strictly separated rooms. 
Nineteen randomly selected products arising from 12 5’B1/2-E5- 3’B1/2-E5, 6 BPV310f/r 
and 1 L1 end F2/E1 start R2 were sequenced. Subsequent Sanger sequencing was performed 
on both strands of the amplified DNA (ABI Prism 3100 Genetic Analyzer, Perkin-Elmer 
Applied Biosystems, Foster City, CA, USA) and chromatograms were assembled using 
4Peaks 1.7.1. 
 
Results 
PV DNA was detected in around 70% of the tested animals (Table 2): in the 37.5 % of skin 
samples whose mucosal samples were found negative, in the 10.7 % of mucous samples 
whose skin samples were found negative and in the 21,42 % of samples from both sampling 
sites. 
In particular BPV-1/2 DNA was detected in 19/32 red deer, 7/13 chamois, 3/5 roe deer and 
5/6 mouflons (17 mucosal samples and 28 skin samples), five deer and three chamois tested 
positive in both compartments. 
Random sequencing of  E5 amplicons demonstrated the presence of  BPV types 1 and 2, as 
well as BPV-1 EqSarc variant (GenBank accession number: JX678969), that shows a single 
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synonymous point mutation (A60G) to date identified in BPV-1 amplified from lesions of 
sarcoid bearing-horses only.  
Identity among BPV-2 amplicons was 100%, among BPV-1 ranged between 99,3%- 100%, 
while EqSarc sequences ranged between 99,3% and 98,5%. 
Xi-genus BPVs were detected in 4/13 chamois, 3/5 roe deer, 3/32 red deer and 1/6 mouflons, 
in this case no subject tested positive both in mucosa and skin. Sequencing was performed on 
all amplicons, but clear DNA sequences were obtained only for samples 32B and 7Z. The 
latter demonstrated 74% identity with BPV-10 (GenBank accession number: KF017607), 
while for sample 32B the identity was 74% with BPV-12 (GenBank accession number: 
JF834524), 73% with BPV-6 (GenBank accession number: AB845589), and BPV3 with 
72.89% identity (GenBank gi|23216976). Further investigations with specific primer pair 
aimed at the identification of BPV-3, 6, 9, 10 between Xi-genus positive samples were 
performed, showing that all the samples were not bearing this viral types.  
Co-infections between Delta and Xi genera were identified in three red deer and three 
chamois.  
No ovine or caprine PVs were detected neither in mouflon nor in chamois’ samples. 
One sample only (15Z), obtained from skin of a red deer, showed positivity for CePV; 
sequencing revealed 100% identity with CePV-1(GenBank JQ744282). The same sample 
tested positive also for BPV-1.  
 
Discussion 
Ubiquity and impressive multiplicity of PV genotypes amongst healthy skin, have been 
documented both in humans (Boxman et al. 1997; Astori et al. 1998; Antonsson et al. 2000) 
and in animals (Antonsson and Hansson, 2002; Lange et al. 2011; Silva et al. 2013), to such 
an extent that papillomaviruses have been described as the first viral skin commensals 
(Antonsson et al. 2000). 
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Species-specific papillomaviruses have been already identified in skin tumors of several wild 
ruminants such as white-tailed deer (OvPV-1), reindeer (RtPV-1), European elk (EePV-1), 
roe deer (CcPV-1) and chamois (RruPV-1) in Europe and North America (Moreno-Lopez et 
al.1981; Stenlund et al. 1983; Groff and Lancaster, 1985; Erdélyi et al. 2008; Mengual Chulià 
et al. 2014). Among healthy subjects belonging to Cervidae, a European elk tested positive for 
specific PVs. 
Antonsson and Colleague (2002) performed analysis on healthy skin from various non-human 
vertebrate species, detecting specific European elk (Alces alces) PVs (EEPV plus three 
putative new EEAA1 to–3) in their host. Mengual Chulià (2014) performed an investigation 
on different species of the Bovidae and Cervidae families and detected DNA belonging to 
PVs infecting cattle, cat, ovine and human, but no species-specific PVs were amplified. 
Xi genus comprises pure epitheliotropic viruses affecting cattle; Delta genus comprehends 
Artyodactila PVs, including BPV types 1 and 2, infecting both epithelia and underlying 
derma’s cells and therefore known as fibropapillomaviruses. BPV1 and 2 are the only PVs 
able to infect cross-species causing common skin tumours of equids termed equine sarcoid, 
but cross-species infection of BPV has also been reported in other animal species.   
In this study the positivity for BPV DNA in nonlesional skin and mucosa of wild ruminants 
was shown. Red deer were the most represented among the tested species (32/56), but 
surprisingly only one CePV, in association with BPV-1, was identified, resembling a co-
infection already described by Scagliarini and colleagues (2013). The Authors identified both 
viruses in a diseased red deer from the Stelvio Park and quantitative analysis demonstrate that 
the CePV-1 DNA yield was four logarithms higher than BPV-1 DNA, confirming that the 
clinical lesions were ascribable to a productive CePV1 infection. 
Among Delta types, the sequenced E5 gene revealed the presence of BPV-1, 2 and BPV-1 
EqSarc1 E5 gene isolate (GenBank accession number JX678969), which presents a single 
nucleotide mutation that was suggested to increase codon usage in equine cells (Chambers et 
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al. 2003). It is noteworthy that to date this mutation has been detected in sarcoid-bearing 
horses only but not in cattle, in addition we report the presence of Eqsarc1 variant in species 
not belonging to the Equidae family. This finding might suggest an “equine adaptation” of the 
virus variant (Nasir and Campo, 2008; Yuan et al. 2007), as this is known to cause lesion in 
horses, but it was also demonstrated to be capable to sub-clinically infect other species. The 
ability of Eqsarc1 variant to asymptomatically infect other species, suggests that wild subjects 
could be the reservoir hosts of this particular PV, and equine sarcoids could be the result of 
repeated cross-species infection (Trewby et. al 2014) by an ancient bovine PV subsequently 
adapted to both Bovidae and Cervidae . A similar situation has been described in cats, where 
the Delta FeSarPV causes sarcoids, but is also asymptomatically present in bovines, and 
therefore a cross-species infection has been suggested (Munday et al. 2010). How the virus 
can spread from non-productive lesions such as sarcoid and whether infection is productive in 
different species is currently unclear even if  Brandt el al (2008) showed the presence of viral 
particle precursors, composed by BPV-1 DNA in complex with the L1 capsid protein, in 
sarcoid samples. No sheep and goats’specific PVs were detected, despite to the fact that the 
presence of these domestic species use to share grazing areas with wild ruminats  from spring 
until autumn. This may suggest a low incidence of infection in domestics, or that PVs of 
sheep and goats known to date might preferentially infect other anatomical sites. 
Roe deer also tested negative for specific PVs,  this further confirms previous findings of an 
extensive investigation performed on the European wildlife disease databases that showed that 
the presence of roe deer fibropapillomatosis had been never detected in many countries such 
as France, Sweden, Germany or United Kingdom. To date, roe deer fibropapillomatosis has 
been documented only in Hungary, this could be linked to the genetic differentiation pattern 
of European roe deer populations or to peculiarities of deer habitat use and geography 
(Erdélyi et al. 2009). 
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Type-specific primer pair didn't succeed to amplify any BPV belonging to the Xi-genus 
despite the positivity obtained with the generic genus specific primer pair, this result could be 
ascribed to sequence variability between the PVs circulating in Italy, as it has been previously 
demonstrated in Brazil (Carvalho et al. 2012).  
Co-infections are common in humans and have been already documented in cutaneous lesions 
of bovines in different countries, but no information is available about the consequences in 
animals. This study demonstrated the presence of co-infections between BPVs belonging to 
Delta and Xi genera in the healthy skin and mucosa of chamois and deer. The frequent 
identification of Delta with Xi BPVs has also been reported in lesions of Brazilian and Indian 
cattle (Claus et al. 2009b; Carvalho et al. 2012; Kumar et al. 2013), suggesting an 
advantageous interaction between these viruses, or that the acquisition of one type of PV may 
facilitate the acquisition of another type.  
Co-infections with two to three HPV types have been also identified in the vagina as well as 
in the skin of more than 50% of healthy subjects (Ma et al. 2014). Our findings show that this 
situation is common also in wild animals and may reflect the overall situation in domestic 
species. The presence of PV DNA in the skin and mucosa of wild ruminants might suggest 
that these compartments may represent a reservoir for bovine papillomaviruses.  
It remains to be determined whether the virus can be spread by the host or not; transmission 
between wild and domestic species is expected to happen via an indirect way, as strict contact 
between subjects is more uncommon. Frequently, wild ruminants share their habitat and 
forage with domestic ruminant species (Ruiz de Ybànez et al. 2009). Under these conditions, 
transmission of infective agents including PVs among domestic and wild animals might be 
enhanced (Daszak and Cunningham, 2000). Due to livestock summer pasturing, this situation 
is very common on the Italian Alps and arthropod vectors may be involved in virus 
dissemination as PCR analysis already demonstrated the presence of the same variants of 
BPV-1 in equine sarcoids and in different flies’ species (Finlay et al. 2009). A similar role for 
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arthropods has also been suggested in the ecology of CcPV1 (Erdélyi et al. 2009). Stool 
samples of different animals tested positive for the presence of specific PVs (Marshall et al. 
1984; Gartrell et al. 2009; Phan et al. 2011). Recently Di Bonito and colleagues (2015) have 
demonstrated the elimination of both mucosal end epithelial PVs with feces in humans, 
confirming that epitheliotropic viruses can find their way into sewage (Cantalupo et al. 2011) 
not only through the washing of skin and mucous membrane, highlighting the possibility of a 
waterborne transmission. Skin from the coronary band and buccal mucosa are both prone to 
traumatic microlesion, in addition these are the body regions in closer contact with ground. 
Bovine papillomavirus type 1 has been shown to survive desiccation in cell extracts for up to 
7 days (Roden et al. 1997), and this might increase infection rates in grazing subjects.  
In conclusion, this study confirms that host tropism in PVs is not as species-speciﬁc as 
previously thought. Althought the presence of the genome of the Delta PV BPV-1 was 
already reported in different animal species, this is first identification of BPV-2 and BPV-1 
and CePV-1 co-infection in the healthy skin of wild ruminants. To our knowledge this is also 
the first report of cross-infections of BPVs belonging to Xi-genus found as single infection 
and in association with Delta BPV types 1 and 2. Taken all together, our results strongly 
suggest the reservoir role of wild ruminants belonging to the Bovidae and Cervidae families 
for domestic ruminant PVs. 
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Table 1- Primer pair for amplification of different PV types and genera  
 
Primer pair Sequence Type of virus Genus Reference 
5’B1/2-E5-  
3’B1/2-E5 
F 5’-CACTACCTCCTGGAATGAACATTTCC -3’ 
R 5’-CTACCTTWGGTATCACATCTGGTGG -3’ 
BPV-1, 2  Delta Brandt et al. 
2008 
BPV310f 
BPV310r 
F 5’ - RACACGGATGABTTTGTYACWCGMAC -3’ 
R 5’ - CCCARTGYTCHCCWTCRCARGG -3’ 
BPV-3, 4, 6, 9, 10, 11, 
12 
Xi Brandt et al. 
2011 
BPV10F 
BPV10R 
F  5’- AAGGCATTTGTGGTCTCGAGG -3’ 
R  5’- CTAAAGAACCACTTGGAGTGCC -3’ 
BPV-10 Xi Carvalho et al. 
2012 
BPV3/6 F 
BPV3/6 R 
F  5’- CAGTCAATTGCAACTAGATGCC -3’ 
R  5’- GGCTGCTACTTTCAAAAGTGA -3’ 
BPV-3, 6 Xi Carvalho et al. 
2012 
BPV9F 
BPV9R 
F  5’- AAAGAGCAAATCGGGAGCACC -3’ 
R 5’- AACTAATGACCCACTAGGGCTCC -3’ 
BPV-9 Xi Carvalho et al. 
2012 
L1 end FII 
E1 start R2 
F 5’- TCCTGGAGCACTGGGACAT -3’ 
R 5’-GCACCTGAGATTCATCATCAC -3’ 
CePV-1 Delta Scagliarini et al 
2013 
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Table 2-Papillomavirus types detected in healthy skin and mucosa of wild ruminants.  
 
Species ID Mucosa Skin 
Chamois 1 - - 
Chamois 2 - - 
Chamois 3 ξ - 
Red deer 4 δ and ξ - 
Red deer 5 - δ 
Red deer 6 - δ 
Red deer 7 δ δ and ξ 
Red deer 8 - - 
Red deer 9 - - 
Red deer 10 - - 
Red deer 11 δ - 
Red deer 12 - - 
Red deer 13 - - 
Red deer 14 - - 
Red deer 15 - δ and CePV-1 
Red deer 16 - δ 
Chamois 17 δ δ and ξ 
Chamois 18 - - 
Red deer 19 δ δ 
Red deer 20 δ δ 
Red deer 21 - - 
Chamois 22 - - 
Red deer 23 - δ 
Chamois 24 - δ 
Red deer 25 - δ 
Chamois 26 - δ 
Red deer 27 δ ξ 
Red deer 28 - - 
Red deer 29 - δ 
Chamois 30 δ δ 
Red deer 31 δ δ 
Chamois 32 δ and ξ δ 
Red deer 33 - δ 
Red deer 34 - δ 
Red deer 35 - - 
Chamois 36 - - 
Chamois 37 δ and ξ - 
Chamois 38 - δ 
Red deer 39 - δ 
Red deer 40 - δ 
Mouflon 41 - δ 
Mouflon 42 - δ 
Mouflon 43 - - 
Red deer 44 - δ 
Red deer 45 δ δ 
Mouflon 46 δ ξ 
Mouflon 47 δ - 
Red deer 48 - δ 
Roe deer 49 - δ 
Roe deer 50 - - 
Mouflon 51 - δ 
Red deer 52 - - 
Roe deer 53 δ ξ 
Roe deer 54 - ξ 
Roe deer 55 δ ξ 
Red deer 56 δ - 
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E5 nucleotide polymorphisms suggest quasispecies occurrence in BPV-1 sub-clinically 
infected horses 
Abstract  
BPV-1 is known as the main causative agent of equine sarcoid, but the virus has also been 
detected in skin and blood of healthy horses. Previous reports demonstrated the presence of 
E5 variants in sarcoids of donkeys and horses; we investigated whether this genetic variability 
might be also found in BPV-1, PBMC associated, of sub-clinically infected horses. With this 
aim, we analyzed the E5 gene of 21 BPV-1 strains from diseased and sub-clinically infected 
horses. Our analyses lead us to demonstrate that multiple virus variants can be present in the 
blood of sub-clinically infected horses, with alternative bases corresponding to either 
synonymous or non-synonymous codons in the E5 oncogene sequences. The results give 
support to the proposed existence of "equine adapted" BPV-1 strains with the occurrence of 
viral variants, resembling quasispecies, in clinically healthy horses with viremia. 
Keywords: horse, bovine papillomavirus; oncoprotein; sarcoid; quasispecies 
 
Equine sarcoid is a common skin tumour of considerable importance in veterinary medicine. 
Bovine Deltapapillomaviruses type 1 and 2 have been recognized as the most important 
etiologic factor in the development of sarcoids, that are characterized by a non-productive 
infection resulting in a fibroblastic tumour with minor epithelial component (Nasir and 
Campo, 2008), in which viral DNA is assumed to exist episomally (Campo, 2002). A wide-
spread occurrence of BPV in the horse population was shown (Bogaert et al., 2008) with a 
30% BPV infection rate of healthy horses not living in contact with cattle or sarcoid-affected 
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horses (Bogaert et al 2005). BPV viral DNA has been demonstrated in whole blood of 
infected cattle (Campo, 1998; de Freitas et al., 2003), and in PBMCs (Peripheral Blood 
Mononuclear Cells) of sarcoid-bearing horses (Brandt et al., 2008a). In sarcoids, only the 
early genes are transcribed, in order to maintain viral copy number and to control cell growth 
(Chambers et al., 2003a). The BPV-1 E5 early protein was one of the first PV oncoproteins to 
be identified. Despite its limited size and unusual composition, the E5 protein causes cell 
transformation and contributes to the establishment of viral infection by promoting cell 
proliferation and immune evasion (Campo, 2002). E5 variants in BPV-1 sarcoid affected 
horses have been identified (Chambers et al., 2003b) further sequence analyses, performed on 
BPV-1 E5 gene of viruses isolated from donkey sarcoids, showed the same nucleotide 
substitutions (Reid et al., 1994). These findings led to the assumption that sequence changes 
could affect the expression and function of the early proteins and may explain the different 
pathogenesis of the equine sarcoid compared to papillomas induced by BPV in cattle 
(Chambers et al., 2003b).  
This study aimed at characterizing the E5 gene of BPV-1 of diseased or sub-clinically 
infected horses, in order to assess the main genetic features of the major oncogene involved in 
sarcoid pathogenesis. A total of 21 horses, aged between 0 and 26 years and belonging to 
private owners were sampled. Ten out of twenty one (15/11, 16/11, 17/11, 19/11, 20/11, 
21/11, 25/11, 36/11, 37/11, 75f/11) were asymptomatic in regard to sarcoid, but were 
previously found to be BPV-1 sub-clinically infected in blood; the remaining 11 subjects 
(2106/11, 1137/10, 231/12, 1407/09, 178/12, 75/11, 688/08, 324/12, 333/12, 322/12, 1219/11) 
were submitted to surgery for the presence of one or more cutaneous neoplasia. 
    Blood samples were collected from sub-clinically infected subjects by jugular venipuncture 
using K3-EDTA-containing tubes and skin samples were collected from sarcoid-bearing 
horses. PBMCs were separated from whole blood using the Ficoll-Paque® PLUS (GE 
Healthcare, Uppsala, Sweden) gradient centrifugation following manufacturer‟s instructions. 
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Genomic DNA was extracted from skin samples and PBMCs using the NucleoSpin® Tissue 
Kit (Macherey Nagel GmbH & Co. KG, Düren, Germany) according to the manufacturer‟s 
instructions.  
Surgical samples were fixed in 10% neutral buffered formalin and routinely processed for 
histological analysis in order to confirm the nature of the lesion. The microscopic examination 
of hematoxylin and eosin stained sections confirmed the clinical suspect of sarcoid 
(Supplemental table 1). 
 Since BPV-1 E5 variants were already demonstrated in sarcoids of horses and donkeys, 
we investigated whether this genetic variability can be also found in the blood of healthy 
horses. PCR amplification of the BPV -1 (499bp) and -2 (497bp) E5 gene was performed as 
previously described by Brandt and colleagues (2008b). Reactions included negative controls, 
no template control (NTC) and a sequenced BPV-1 strain used as a positive control. E5 was 
not detected in negative controls and NTC, while all the sarcoid-bearing subjects were found 
positive for BPV E5 gene and all the healthy horses confirmed to be sub-clinically infected. 
The only BPV type identified in the analyzed samples was type 1 giving further support to the 
evidence that in Europe this accounts for the vast majority of DNA detected (Angelos et al., 
1991; Otten et al., 1993). The presence of BPV-1 DNA in the peripheral blood of healthy 
subjects further proves that blood might be a reservoir of viral DNA as previously reported by 
Brandt et al., 2008a. As a first screening for the characterization of PCR products, restriction 
enzyme analyses with MaeIII (Roche Molecular Diagnostics, Mannheim, Germany) have 
been performed thus being able to detect the nucleotide mutations at position 60 in the E5 
gene (Chambers et al. 2003b). Subsequently, the amplicons were purified and directly  
sequenced by forward and reverse primers. Alignments of the assembled sequences were 
further viewed and adjusted using BIOEDIT program version 7.2.0 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). Chromatograms were visually inspected 
showing that those from sarcoid-bearing horses didn’t lead to identify any ambiguous base. 
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Instead, the analysis of the sequences from 5 healthy subjects (16/11, 17/11, 20/11, 25/11, 
37/11) showed clear single-nucleotide polymorphisms (SNPs) at different nucleotide 
positions in the whole sequence (Figure 1) corresponding either to non- synonymous or 
synonymous triplets (Table 1). MaeIII digestion emphasized the presence of one or more viral 
sub-populations in every sample, confirming what was previously evidenced by 
chromatogram analysis. 
The amplification products, suggesting the presence of mixed viral populations, were cloned 
into the pDriveCloning vector (Qiagen, Hilden, Germany). Positive clones were screened by 
PCR and MaeIII restriction enzyme digestion. On the basis of the identified pattern, a 
minimum of 2 and a maximum of 4 recombinant plasmids for each sample were purified and 
sequenced. 
The nucleotide sequences obtained were compared to reference BPV-1 (GenBank accession 
number: NC_001522) and equine sarcoid (GenBank accession number: JX678969) using 
CLUSTAL W. 
The E5 sequences, amplified from all sarcoid samples, showed the non-coding nucleotide 
substitution A/G at position 60 (Brandt et al., 2008b; Chambers et al., 2003b). This 
substitution was the only one identified in samples 324/12 and 1219/11. The single non-
coding substitution T/C at position 9 was evident in samples 1407/09, 178/12, 688/08 and 
75/11 while stop codon TAA was substituted by TAG in sample 333/12. Samples 333/12, 
322/12, 231/12, 1137/10 and 2106/11 showed the coding G/T substitution at position 43, 
which leads to the change of an alanine with a serine amino acid residue. Four samples 
(75/11, 688/08, 1407/09, 178/12) were conducible to the prototype sequence of BPV-1 E5 of 
equine sarcoid (GenBank accession number: JX678969). 
Analysis of the complete 135bp E5 gene sequences confirmed that the chromatogram 
polymorphism was determined by the presence of different viral populations (Supplemental 
figure 1). A total of 7 different point mutations were identified in the 14 analyzed clones 
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(Table 1). Besides the mutations at positions 43 G/T and 60 A/G, other five changes at 
different positions are reported for the first time (Table 1). Our results support the existence of 
an “equine adapted” BPV strain that infects horses in addition to the prototype BPV. In fact, 
we found the single non-coding mutation A60G in two out of 5 sub-clinically infected horses, 
in at least one clone from each healthy sample, while this mutation is constantly identified in 
sarcoid-bearing horses. This hypothesis is further supported by the findings of Trewby (2012), 
who stated that the emergence of a slowly evolving virus in horses is unlikely to be a recent 
phenomenon and cannot be attributed to a single cross-species transmission event. 
It has already been documented that the variants detected in equine sarcoids might increase 
codon usage in equine cells (Chambers et al., 2003b; Nasir et al., 2007; Nasir and Reid, 
1999). This is interesting, particularly for the E5 gene, as these variants would be expected to 
be translated more efficiently in equine cells to increase the cell transformation efficiency 
(Nasir and Campo, 2008). 
According to the Codon Usage Database (http://www.kazusa.or.jp/codon/) it was evident that 
the synonymous triplets CUG and CUA are used with the same frequency in cattle (43.5‰, 
6.1‰ respectively) and horse (44.7‰, 6.0‰ respectively). These data support the hypothesis 
that „equine-adapted‟ BPV-1 have the same ability to infect equids of „bovine-infecting‟ 
BPV-1. Thus, this finding is in contrast with the assumption that papillomaviruses use rare 
codons relative to their hosts (Zhao et al., 2005; Zhao et al., 2003). 
The genetic heterogeneity of BPV-1 E5 gene found in sub-clinically infected horses might 
suggest the occurrence of quasispecies (Eigen, 1996). Quasispecies are widely recognized in 
RNA viruses having error prone mechanisms for replication of nucleic acids. In contrast, 
DNA viruses use the host replication system with high fidelity, good proof reading capacity, 
and efficient post replication repair capacity. Previous reports described viral genomic 
diversity in individual clinical specimens among DNA viruses both in humans and animals 
(Battilani et al., 2006; Luo et al., 2012) but physiological significance in viral activity have 
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not yet been fully understood. In humans, the simultaneous presence of multiple viral variants 
within E6 gene in the same subject, has already been reported for HPV-16 in precancerous 
cervical biopsies (Vartanian et al., 2008) and in invasive cervical cancer as well as in low-
grade squamous intraepithelial lesion (Kukimoto et al., 2013). Our findings may suggest a 
parallel behavior within the E5 gene of BPV with the presence of quasispecies representing a 
pre-cancerous state in horses. 
In contrast to what it has been detected in sarcoid-bearing donkeys (Reid et al., 1994) and 
horses (Chambers et al., 2003b), where all samples contained the same E5 variant, in sub-
clinically BPV-1 infected horses, we demonstrated the co-existence of both mutated and non-
mutated sequences. Our findings might support the hypothesis that these sequence variants 
possess a particular selective advantage within equids. 
In summary, we report for the first time sub-clinically infected horses carrying multiple 
strains of BPV with a variability detected in the E5 oncogene, which indicates that 
quasispecies may be common in the context of BPV sub-clinically infected horses. In depth 
research will be needed to better understand whether sequence variants can be identified as 
prognostic factors for disease development. 
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Figure 1- Unprocessed raw chromatogram depicting minor peaks, representative of the quasispecies' genotypes, 
that can be seen under the highlighted major peaks from a BPV-1 sub- clinically infected horse. MaeIII 
restriction site (↓GTNAC  is evidenced (boxed) at position 60 of the E5 sequence where a mixed population is 
identified by the double peaks. 
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Table 1- Nucleotide substitutions in clones of BPV-E5 in sub-clinically infected horses. Different nucleotides 
are indicated by a letter; the nucleotides identical to the reference sequence (GenBank accession number 
NC_001522) are indicated as dashes while the nucleotide differing are written. Nucleotide changes which result 
in amino acid substitutions are indicated with the deduced amino acid changes. Nucleotide position is referred to 
the E5 gene sequence. 
Nt. E5 gene 39 42 43 46 60 7
8 
117 
NC_001522 T T G A A G T 
16 clone 1 - - T - G - - 
16 clone 2 - - - G - - - 
17 clone 1 - - - - - A - 
17 clone 2 - - T - G - - 
17 clone 3 - C - - G - C 
20 clone 1 - - - - G - - 
20 clone 2 - - C - G - - 
20 clone 3 - - - - G - - 
20 clone 4 - - - - G - - 
37 clone 1 C - - - G - - 
37 clone 2 - - - - - - - 
25 clone 1 - - - - - - - 
25 clone 2 - - T - G - - 
25 clone 3 - - T - G - - 
aminoacid 
substitutions  
ValVal AlaAla G/C AlaPro 
G/T AlaSer 
MetVal LeuLeu LeuLeu CysCys 
 
 
 
Supplemental figure 2- Complete alignment of BPV-1 E5 gene sequences of reference strains, clones obtained 
from sub-clinically infected animals and sarcoid bearing horses. MaeIII restriction site (↓GTNAC  is identified 
only in sarcoid bearing horses and in several BPV-1 variants (clones) of the mixed populations found in sub-
clinically infected animals. 
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Supplemental table 1- Sarcoid samples and their localization. Histological examination confirmed the 
cutaneous tumors as sarcoids in all 11 cases. Based on Knottenbelt (2005), the clinical pattern was fibroblastic in 
5 cases, verrucous in 2, mixed in 2, 1 nodular and 1 occult. Histologically, according to Martens et al. (2000), 
hyperkeratosis and epidermal hyperplasia varied from mild (3 cases) to moderate/marked (6 cases); epidermis 
showed thinning in 2 cases and partial surface ulceration in 5; cell palisading at the dermal-epidermal junction 
was evident in 8 cases and rete pegs in 6; as for the dermal proliferation, neoplastic fibroblast were densely 
packed in 9 cases, with typical whirling pattern in 7 cases. 
Sample n° Type of lesion Localization 
75/11 Mixed inguinal area 
1137/10 Verrucous neck 
1219/11 Mixed ventral abdomen 
2106/11 Verrucous pastern 
178/12 Fibroblastic chest 
231/12 Fibroblastic inguinal area  
688/08 Fibroblastic  chest 
1407/09 Fibroblastic inguinal area 
324/12 Occult chest 
333/12 Nodular perinaeum 
322/12 Fibroblastic ventral abdomen 
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IV 
GENERAL DISCUSSION AND CONLCUSIONS 
 
Animal PVs have provided powerful models for antiviral vaccines development for humans 
(Campo, 1997), this is particularly true for some animal PVs including COPV (Teifke et al., 
1998), CRPV (Rous et al., 1935), Rhesus papillomavirus (RhPV) (Ostrow et al., 1990), and 
BPV (Campo et al., 1992) that share with the High Risk HPVs the ability to transform their 
host cells and lead to the development of cancer. During the past 50 years, studies of BPV-
associated lesions have been useful in helping to understand the complex relationship between 
HPVs and human cancer. In addition, unlike HPVs, BPVs were found to readily transform 
cells in vitro, and BPV-transformed cells have been valuable in determining how PVs cause 
cancer (Meischke, 1979). 
The identification of the PV viral types, causing infections in animals, is also necessary to 
understand the geographical distribution and pathology of PV and to develop proper 
prophylactic and therapeutic measures. Despite a broad documentation of the incidence of 
BPVs in cattle herds in various regions of the world (Singh et al., 2009; Schmitt et al., 2010; 
Freitas et al., 2011; Carvalho et al., 2012) scant information about the types distribution in 
Italy is available (Borzacchiello et al., 2003a, 2003b; Roperto et al., 2014; Grindatto et al., 
2015). The survey described in PAPER I contributed to fill the gap regarding the lack of 
information on the BPVs circulating in Emilia Romagna region and hypothetically on the 
Italian territory. This first study depicts a situation of heterogeneous infections, where the 
frequency of the combinations observed reproduces and may depend on the diffusion of the 
single genera in the country. We identified all four BPVs genera, hence types 1, 2, 3, 6, 7, 8, 
9, 10 and 12 in a total of xx samples.  BPVs 6, 7, 8, 10 and 12 where described for the first 
time in Italy.  
The multiplicity of viral types identified, even inside single herds, add significant knowledge 
about the prevalence and diversity of BPV infection. This information may be used in future 
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studies aiming at the development of more specific treatment and diagnostic methods. Our 
results confirm what was previously observed in other countries about the high frequency of 
co-infections (Schmitt et al., 2010; Carvalho et al., 2012; Santos et al., 2014), in fact more 
than a half of the samples harbored different genera, hence PV types. The high prevalence of 
co-infections observed in our and in other studies, may suggest that different BPV types do 
not interfere with each other even though it is still unknown whether the lesions are caused by 
one type only and the other types are passengers, whether they are biologically active and 
what their viral load is (Schmitt et al., 2010). In general, the identification of multiple BPV 
infections may contribute to the understanding of the epidemiological, and the clinical 
features as well as the oncogenic potential of the virus and the relationship between virus and 
co-factors in developing cutaneous papillomatosis in cattle. 
A more detailed characterization of the genomes of BPV-7 variants amplified from nine teat 
skin lesions of dairy cows collected during the previous survey is performed in PAPER II.  
Direct sequencing of the entire genome was feasible only for two viral strains, the Italian 
variants BPV-7 #215 and #221 that showed major sequence differences in the long control 
region (LCR) and in the L2 gene compared to the Japanese reference strain, where it was 
firstly identified in diseased and healthy teat skin samples (Ogawa et al., 2007). In order to 
better define the stability of the variants, particular attention was given to the L2 and LCR 
amplicons of the 7 remaining partially sequenced samples. The deletions and insertions 
identified in our specimens are consistent with previous findings in different papillomavirus 
types identified in Arctiodactyla (Scagliarini, et al., 2013; Zhu et al., 2014; Dong, et al., 
2013), but genomic duplication, insertion and deletion have been also detected in the LCR 
region of HPV- 6 and -11 where these rearrangements have been shown to be associated with 
clinically malignant or malignant tumors (Kasher et al., 1988; Chin et al., 1989; Favre et al., 
1990; Rübben et al., 1992; Kitasato et al., 1994;). 
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Our findings evidenced intra-type variability of BPV-7 L2 and further studies on variants will 
clarify the consequences of the amino acid deletions on the antigenicity and will add 
information on functional motifs of this PV structural protein. Analyses of the modified LCR 
region by functional assays suggested that activity of this regulatory region was in some cases 
enhanced (Wu and Mounts, 1988) while in others, insertions and duplications did not 
influence the protein expression (Combrinck et al., 2012). 
Our identification contributes to the understanding of BPV and PV replication and 
transcription, confirming that deletions but also insertions can be observed in other BPV-
positive papilloma samples. Whether the genetic BPV-7 variants possess distinct biological 
properties in vivo, remains to be determined and  further studies will be necessary to detect the 
functionality of the deleted genome  to confirm if this kind of genome's deletions have 
implications in disease progression.  
The objective of Paper III was to determine the causes of several outbreaks of malignant 
proliferative skin diseases in domestic ruminants in Sicily during 2011-2014 that were 
clinically diagnosed as papillomatosis. This study enlighted he presence of different BPV 
genera and types (i.e BPV1, 2, 6, 7, 8) both as single or multiple infections, confirming what 
previously had been reported in Paper I for Emilia Romagna. Due to the peculiar features of 
the tumor-like lesions found in Sicily pathological samples were also screened with a mini 
array test for the rapid detection of zoonotic poxviruses developed within POC4PETS FP7 
project. Analysis demonstrated papillomavirus co-infections with parapoxviruses in seven out 
of twelve cows. Furthermore, two cattle that showed the presence of papillomavirus particles 
by EM were also co-infected with zoonotic CPXV belonging to Orthopoxvirus genus. Even if 
it was not possible to conclude that CPXV was the causal agent of the malignant lesions for 
its low genomic load showed by Real time PCR performed on samples. On the other hand the 
presence of CPXV DNA identified in the pathological samples of diseased cattle and goats 
from the same area lead us to speculate that the virus may use these animal species as 
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reservoirs to spread and persist in the environment through the scab material produced by 
epitheliotropic BPVs containing high titers of stable viruses that can remain infectious long 
enough to sustain indirect transmission of both viruses. Papillomavirus and poxvirus 
infections recognize the same risk factors caused by highly resistant agents, in addition both 
viruses have a particular tropism for epithelial cells, but they do not necessarily require direct 
contact between infected and susceptible host to be transmitted. Poxvirus zoonoses fall into 
the category of neglected ones and their incidence in animals and humans is often unknown or 
greatly underestimated, therefore early recognition of the etiologic agents allows proper 
control measures and disease management strategies to prevent disease spread among animals 
and humans in the case of zoonotic viruses. 
The results of PAPER III suggest a further biological role of BPVs which can contribute to 
the spread of other epitheliotropic viruses, including those responsible of zoonoses, by 
promoting their target cells proliferation in a Trojan horse fashion.  
Skin tumors are also common in wildlife species, in particular the genomes of several cervid 
papillomaviruses have been sequenced, such as the Deer (White-tailed deer – Odocoileus 
virginianus) Papillomavirus, the Reindeer (Rangifer tarandus) Papillomavirus, the European 
Elk (Alces alces) Papillomavirus and the Western roe deer (Capreolus capreolus) 
papillomavirus. The majority of cervid papillomaviruses belong to the Delta genus, whose 
components have the common feature of inducing the development of skin tumors with a 
marked connective tissue component. Investigation on a firm cutaneous tumor of a male red 
deer shot in the Italian Alps in Brescia province is described in PAPER IV. Viral particles, 
identified by morphologic features as PV were observed by negative stain electron 
microscopy, histological examination classified the tumor as a fibropapilloma and a 
subsequent molecular investigation demonstrated the presence of both BPV1 and CePV1 
DNA. The coinfection of a red deer with BPV1 is not surprising and confirms the host-
jumping ability of the virus. . The genetic organization of CePV1exhibits a typical Delta 
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papillomavirus architecture, in addition CePV1 is the closest relative of CcaPV1 identified in 
roe deer (Capreolus capreolus), where red deer and roe deer belong to the 2 different 
subfamilies Cervinae and the Capreolinae. Our data therefore indicate that these PVs belong 
to the same ancestral lineage and infection of a different host can be the result of a host switch 
event. In fact, even though co-divergence plays an important evolutionary role in PVs, it is 
not the only event that shaped PV diversification (Gottschling et al., 2011), since other events 
such as duplication and host switching can disrupt the topological congruence between the 
phylogenetic trees of Delta papillomaviruses and their hosts. Interspecies transmission of 
viruses is a broadly accepted phenomenon but it is still debated whether it requires adaptation 
to a new host during the early stages of infection or whether transmission itself could be a 
largely random process (Dennehy et al., 2006). PAPER V regards a molecular investigation of 
cutaneous and mucosal healthy samples collected from sites naturally exposed to microlesions 
demonstrated the presence of a CePV1 and BPV1 co-infection in a red deer. In the same 
study, amplification of Delta (BPV1, 2, EqSarc BPV1) and Xi BPVs widen information on 
biology of the virus providing new data about host range, tropism and dissemination. Xi genus 
is comprised of pure epitheliotropic viruses affecting cattle; to our knowledge this 
identification as a single infection or in association with Delta papillomavirus types 1 and 2 
serves as the first description of their ability to infect other hosts, in particular asymptomatic 
ones. Among Deltapapillomavirus types, the sequenced E5 gene revealed the presence of 
BPV1, 2 and BPV1 EqSarc1 E5 gene isolates (GenBank accession JX678969), which 
presents a single nucleotide exchnge that was suggested to increase codon usage in equine 
cells (Chambers et al., 2003). This mutation has been detected in sarcoid-bearing horses 
(Equus caballus) but not in cattle; furthermore, we identified the Eqsarc1 variant in non-equid 
species. This finding might suggest an “equine adaptation” of the virus variant (Yuan et al., 
2007; Nasir and Campo 2008), as this is known to cause lesions in horses, but it was also 
demonstrated to infect other species subclinically. The ability of Eqsarc1 variant to 
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asymptomatically infect other species suggests that wildlife could be a reservoir for this 
particular PV, and equine sarcoids could be the result of repeated cross-species infection 
(Trewby et al., 2014) by an ancient bovine PV subsequently adapted to both Bovidae and 
Cervidae. A similar situation was described in cats, where the Deltapapillomavirus FeSarPV 
causes sarcoids but is also asymptomatic in bovines; therefore, cross-species infection has 
been suggested (Munday and Knight 2010). 
More evidence to the presence of an “equine adapted” BPV1 strain that infects horses in 
addition to the prototype BPV is given in Paper VI, where the genetic heterogeneity of BPV1 
E5 gene found in sub-clinically infected horses might suggest the occurrence of quasispecies 
(Eigen, 1996). This hypothesis is further supported by the findings of Trewby (2012), who 
stated that the emergence of a slowly evolving virus in horses is unlikely to be a recent 
phenomenon and cannot be attributed to a single cross-species transmission event. In contrast 
to what it has been detected in sarcoid-bearing donkeys (Reid et al., 1994) and horses 
(Chambers et al., 2003b), where all samples contained the same E5 variant, in sub-clinically 
BPV1 infected horses, we demonstrated the co-existence of both mutated and non-mutated 
sequences. Our findings might support the hypothesis that these sequence variants possess a 
particular selective advantage within equids. 
 Current classification system assumes that the host species, in which a PV was firstly 
detected is in fact the original host, and the identified types are therefore named after it. Both 
Paper IV and V, in accordance with Bravo et al. (2010), claim that the current PV 
classification system should be revised and an alternative naming approach should be 
considered, since host specificity is not always strictly maintained in animal papillomaviruses. 
In summary, we bring to light a kaleidoscopic situation of BPVs infection in different 
domestic and wild species. Further studies will be needed to identify other species that can be 
sub clinically infected, as well as to better understand their role in infection maintaining and 
transmission. The latter aspect is also fundamental in clinically infected subjects, in fact, 
135 
although a causal relationship between BPV1 and equine sarcoids is well established, how 
Equidae become infected with BPV1 remains unknown. In general, understanding the 
phylogenetic relationships and mechanisms driving PVs diversification will provide better 
insight into viral evolution and virus–host interactions.  
 
